ID	Description	GeneRatio	BgRatio	pvalue	p.adjust	qvalue	geneID	Count
WP2806	Complement system	66/3955	73/5488	0.000109139770636155	0.0602451533911578	0.0572122166071636	133/409/708/715/716/717/719/720/722/727/728/729/811/930/958/4179/1604/966/22918/629/1675/3075/3426/5199/1378/1380/1634/2159/2160/2161/2208/2214/2219/2286/2357/2769/2771/2773/3383/3384/3673/3687/3689/3690/3818/3911/3912/3915/5648/5329/5566/5621/5627/5806/6401/6402/6403/6404/710/729238/6696/7057/7097/7295/11326/7454	66
WP2328	Allograft rejection	63/3955	70/5488	0.000219983119792311	0.0607153410626779	0.0576587335034584	5243/712/713/714/717/720/721/727/729/836/841/842/6363/958/959/1604/941/942/1289/1459/1493/6373/6387/4283/643/355/356/50943/2551/10578/3002/3105/3106/3107/3108/3109/3111/3112/3113/3115/3117/3118/3119/3122/3123/3133/3134/3135/3552/3553/3559/120892/100507436/5156/55825/5551/5590/6772/7040/7124/10376/7422/7431	63
WP5095	Overview of proinflammatory and profibrotic mediators	50/3955	57/5488	0.00388262511444315	0.400104980780221	0.37996239593545	6356/6357/6362/6363/6347/6364/6367/6368/6369/56477/6348/6351/6355/1435/1440/6376/2919/3627/6373/6387/58191/2920/2921/6374/6372/4283/10148/3589/3600/3606/3552/3553/3557/11009/90865/3569/3976/4049/4312/4314/4318/4790/5008/6696/7040/7124/8741/10673/7422/6375	50
WP558	Complement and coagulation cascades	40/3955	45/5488	0.00580678748145124	0.400104980780221	0.37996239593545	712/713/714/715/716/717/719/721/728/729/4179/1604/629/1675/3075/3426/1191/1378/1380/2159/2161/2149/2152/2153/2157/3818/3827/3998/5648/5327/5328/5329/5627/5265/5104/5054/710/7035/7056/7450	40
WP2877	Vitamin D receptor pathway	104/3955	127/5488	0.00657699307039194	0.400104980780221	0.37996239593545	5243/215/11096/154/8853/490/9914/654/768/838/875/892/595/898/929/958/928/997/1017/54901/1026/1030/1045/634/9075/23274/79789/1305/1493/1594/1555/29785/1576/1577/1673/1946/2050/2308/50486/2539/1647/3091/29923/3117/3118/3123/6927/3294/3397/3488/9173/3662/3663/3684/3726/9365/9314/3827/3965/4041/126364/56262/55090/4600/4084/4609/4773/4814/27035/8204/5467/639/5734/6256/6275/6277/6279/6280/6304/7869/1992/6422/10568/219855/6546/25928/6696/8027/79689/412/6819/7040/7056/7077/7078/7128/4982/8600/7292/7168/22906/54210/7421/113835	104
WP2817	Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4)	21/3955	22/5488	0.00698313828275692	0.400104980780221	0.37996239593545	9914/598/857/595/1051/1147/1956/1977/2064/2065/3717/4609/2908/5618/5770/8792/8600/7170/23508/7392/7528	21
WP2911	miRNA targets in ECM and membrane receptors	21/3955	22/5488	0.00698313828275692	0.400104980780221	0.37996239593545	1278/1281/1282/1284/1289/1290/50509/1291/1292/1293/2335/3672/22801/3693/3694/3910/3913/3915/6383/7057/7058	21
WP4790	FGF23 signaling in hypophosphatemic rickets and related disorders	15/3955	15/5488	0.00729051574047562	0.400104980780221	0.37996239593545	249/595/1026/1594/5167/56975/2263/2261/2591/9365/4790/4791/5251/142680/6696	15
WP4726	Sphingolipid metabolism: integrated pathway	20/3955	21/5488	0.00930719008827669	0.400104980780221	0.37996239593545	427/64781/29956/79603/91012/253782/8560/123099/2531/259230/166929/8879/81537/130367/6609/8877/56848/9517/7357/7368	20
WP5087	Malignant pleural mesothelioma	276/3955	356/5488	0.00932296855361097	0.400104980780221	0.37996239593545	59/60/72/9510/84962/207/84335/10000/154796/284/285/324/171023/1386/467/472/8312/9532/578/580/27113/596/685/8945/834/6347/6351/595/894/898/29126/960/961/999/1009/1012/1015/28513/64403/1001/1003/1004/1017/1019/1022/1026/11113/1282/1284/1285/1385/1435/1436/1440/1454/1457/1459/283106/1460/1488/115908/1499/8454/2919/3627/6387/6374/80319/64798/1855/1856/8726/1942/1944/1945/1946/1956/1975/1978/1981/2002/1969/2258/2247/2252/2254/2260/2263/2261/2321/2322/2324/2335/2305/2308/10023/23401/7976/7855/8323/8324/8325/2551/1839/3082/3091/3150/3620/3479/3481/3553/146433/3569/3643/3672/3673/3675/3676/3655/3685/3688/3689/3690/3691/3710/7403/3791/9493/3815/4254/58508/83999/284217/3908/3910/3911/3912/3913/3914/3915/3918/10319/26524/3965/4041/4040/4085/5604/5605/5606/5607/5608/5609/4214/4296/10746/4215/4216/4217/9064/4293/11184/5871/9448/5602/5595/5599/5601/9261/4170/90550/4192/4193/4194/4209/50488/8569/2872/4323/4313/4314/4318/55233/92597/4485/4609/10397/4790/4804/114548/4915/5058/5062/10298/5154/5155/80310/5156/5159/5163/5228/5281/5290/5291/5294/5328/5332/5420/64840/10891/5564/5565/5571/51422/11098/5728/5894/11186/283349/83937/83593/166824/8045/9821/5928/6009/6045/4919/4920/6194/6195/6198/57521/6259/60485/6401/59343/5176/29072/6422/6423/6425/6464/8140/6654/6678/6714/6772/6788/23512/6932/83439/6934/7003/8463/7004/7010/9894/7039/7040/7248/7249/29128/8408/9706/7422/7424/7482/7473/54361/7474/81029/23286/25937/10413/7528	276
WP12	Osteoclast signaling	14/3955	14/5488	0.0101264357176766	0.400104980780221	0.37996239593545	54/7965/9550/1513/8111/3454/3690/5599/5155/6548/6696/8792/4982/8600	14
WP3935	Leptin-insulin signaling overlap	14/3955	14/5488	0.0101264357176766	0.400104980780221	0.37996239593545	207/8525/3643/3667/8660/3717/3953/5170/5294/8503/8651/8835/9021/6774	14
WP3617	Photodynamic therapy-induced NF-kB survival signaling	29/3955	32/5488	0.0103889653343707	0.400104980780221	0.37996239593545	597/599/329/330/332/595/959/8837/1147/2920/3383/3552/3553/3569/4312/4313/4314/4318/4790/4791/5743/5966/5970/6401/7124/7132/7189/7412/7422	29
WP2858	Ectoderm differentiation	84/3955	102/5488	0.0105888830926329	0.400104980780221	0.37996239593545	10257/54806/79658/23229/11177/54828/54880/657/91653/56913/6347/1004/50937/1499/2263/2274/3170/2300/2534/8322/7855/8325/10634/2627/2720/2737/57476/10013/3148/3728/54207/9079/4061/9935/4204/54903/4609/7593/4772/51701/7026/4926/9924/5150/5236/23133/5297/5292/345557/5362/5420/5452/5467/8495/51422/5783/5787/51762/56963/6016/4920/6238/6386/5269/27352/6469/4089/8835/10253/7903/6781/8675/6929/83439/4982/27324/51592/7226/8848/7343/54521/57621/51043/51222	84
WP4725	Sphingolipid metabolism overview	19/3955	20/5488	0.0123815201358901	0.400104980780221	0.37996239593545	427/64781/29956/79603/253782/8560/123099/2531/259230/166929/8879/81537/130367/6609/8877/56848/9517/7357/7368	19
WP5198	Inflammatory bowel disease signaling	28/3955	31/5488	0.0132058541031428	0.400104980780221	0.37996239593545	50943/2625/3108/3459/3594/3595/3606/8807/3552/3561/3566/3569/4094/4772/4790/64127/6095/6097/6772/6774/6775/6778/30009/7040/7097/7099/7100/7124	28
WP2431	Spinal cord injury	72/3955	87/5488	0.0140186054350642	0.400104980780221	0.37996239593545	199/301/358/7832/713/727/836/6347/595/900/729230/961/998/1017/1019/50515/1280/1282/1464/2919/3627/2920/1956/1958/2043/2212/2280/2353/1647/2697/3383/3552/3553/3554/3569/3958/10288/1241/5595/4155/4282/4321/4318/4609/4804/4843/9423/5320/8398/5362/5530/5743/5879/5925/56963/387/388/389/9475/57142/6403/57556/6662/7040/7099/7124/8741/10673/1462/7431/64131/7538	72
WP4760	PKC-gamma calcium signaling pathway in ataxia	13/3955	13/5488	0.0140644940523286	0.400104980780221	0.37996239593545	767/773/2767/9630/2769/2776/2893/3708/5163/23236/5330/5331/5332	13
WP5174	Ulcerative colitis signaling	13/3955	13/5488	0.0140644940523286	0.400104980780221	0.37996239593545	50943/2625/3108/3561/3566/4094/4772/4790/64127/6778/7040/7097/7124	13
WP5055	Burn wound healing	75/3955	91/5488	0.014852966646887	0.400104980780221	0.37996239593545	43/8038/207/596/23476/836/6347/57124/1139/1265/1277/1278/2919/6387/3579/1634/2200/2260/2263/2261/2335/60674/3082/3383/3600/3552/3553/3569/3624/3791/9314/3956/23643/406937/4312/4322/4313/79148/4314/4318/100463486/4790/4792/64332/10392/64127/5159/5216/6282/6277/6280/8796/871/6423/4088/6591/6678/6876/7040/7043/7076/7077/7096/7097/7098/7099/7100/10333/51311/54106/3371/7124/7128/7422/7431	75
WP4304	Oligodendrocyte specification and differentiation, leading to myelin components for CNS	18/3955	19/5488	0.0164378866244175	0.400104980780221	0.37996239593545	650/1267/2919/2920/2247/2736/3479/3553/3976/4155/5155/5354/6469/6660/55553/30812/6662/7124	18
WP4136	Fibrin complement receptor 3 signaling pathway	31/3955	35/5488	0.0172148693441113	0.400104980780221	0.37996239593545	207/868/6347/929/1147/3627/2921/8517/3569/3654/3656/3684/3689/23643/4790/4843/5290/5327/83593/5966/5970/387/6714/6850/148022/114609/7098/7099/7124/7189/7305	31
WP2813	Mammary gland development pathway - Embryonic development (Stage 1 of 4)	12/3955	12/5488	0.0195326323688946	0.400104980780221	0.37996239593545	207/249/595/999/1364/3655/3688/4609/6422/7040/7124/9839	12
WP4724	Omega-9 fatty acid synthesis	12/3955	12/5488	0.0195326323688946	0.400104980780221	0.37996239593545	10965/2180/2181/2182/64834/60481/79071/3992/9415/2194/6319/79966	12
WP453	Inflammatory response pathway	22/3955	24/5488	0.0197403346580633	0.400104980780221	0.37996239593545	958/959/941/942/1277/1278/1281/2335/3559/3560/3561/3566/3911/3912/3913/3915/3918/3932/7057/7059/7132/7133	22
WP2203	Thymic stromal lymphopoietin (TSLP) signaling pathway	38/3955	44/5488	0.0202048722729815	0.400104980780221	0.37996239593545	207/695/6356/1154/1978/2242/2534/3055/3559/3569/3575/3717/3932/4067/5604/5605/5595/5599/5601/4609/4790/4791/4792/55361/5290/5781/5970/6194/6714/6772/6774/6775/6776/6777/6778/7006/7292/7525	38
WP34	Ovarian infertility	17/3955	18/5488	0.0217747772430006	0.400104980780221	0.37996239593545	472/894/1019/1051/1958/2701/4292/9611/8204/5618/5732/4088/6609/23224/6908/7421/7784	17
WP3599	Transcription factor regulation in adipogenesis	17/3955	18/5488	0.0217747772430006	0.400104980780221	0.37996239593545	1051/1052/1385/2308/3569/3643/3667/8660/23175/5599/2908/8204/5106/5468/10891/6256/7124	17
WP5194	Synthesis of ceramides and 1-deoxyceramides	17/3955	18/5488	0.0217747772430006	0.400104980780221	0.37996239593545	53947/427/84002/2683/64781/29956/79603/91012/253782/1674/8694/2531/259230/166929/8877/7357/7368	17
WP455	GPCRs, class A rhodopsin-like	72/3955	88/5488	0.0230630445694184	0.400104980780221	0.37996239593545	51554/136/150/153/154/187/624/719/1230/729230/1234/10803/9034/1131/1240/1268/1269/3577/3579/2833/643/10800/57105/1909/1910/2149/2150/2151/9002/2867/2357/2358/2359/2838/23432/29909/84636/2841/2859/9283/2863/8477/8111/8843/3269/3352/3360/57121/10161/1241/4886/5540/4888/23596/5028/5032/64805/53829/9934/5029/5030/5031/5724/5729/5732/5734/5737/23637/6751/6752/56670/2829	72
WP3624	Lung fibrosis	41/3955	48/5488	0.0231217218741647	0.400104980780221	0.37996239593545	23250/655/6356/6347/6348/6351/729230/1051/1215/1440/2920/57105/1832/1906/255520/10144/2247/2252/26585/3082/3162/3479/3553/3569/4204/4313/4318/727897/5073/5154/5155/5328/5806/5265/729238/4092/6696/7039/7040/7076/7124	41
WP236	Adipogenesis	85/3955	105/5488	0.0231944916394331	0.400104980780221	0.37996239593545	10555/196/649/650/651/1026/1051/1052/10658/1675/55847/1271/1385/1499/56603/1855/1879/1959/2034/355/2308/1647/4616/2624/2625/2971/3091/6927/3399/3479/3569/3572/3667/8660/688/8609/3976/3991/4000/23175/64900/4023/4154/4208/4209/4282/10135/8648/10499/9611/4692/7025/2908/8204/5008/5105/5106/123/5465/5467/5468/10891/5618/5914/5925/5934/6095/6256/6319/5054/4088/8651/9021/6695/6772/6773/6774/6776/6777/6778/7040/7124/57761/81029/25937	85
WP4239	Epithelial to mesenchymal transition in colorectal cancer	97/3955	121/5488	0.0255293526262717	0.404672753490822	0.384300212125151	207/10000/999/9076/9069/24146/51208/9075/1365/1364/7122/1366/9073/1282/1284/1285/92359/58190/1499/28514/54567/1832/8726/56648/114793/2335/2305/7976/8322/7855/8323/8324/8325/3091/3397/3398/3678/3714/3728/26524/4041/4040/5604/5605/5606/5608/5600/6300/5603/5595/5599/4209/4324/4313/4318/4853/4854/4855/7182/8828/80224/100506658/5058/10016/5290/5291/5295/5296/8503/5894/5928/3516/6464/4088/4089/6591/6654/6655/6678/11171/23512/7040/7043/7046/7048/7082/56649/7189/7991/7482/7473/54361/7474/81029/7483/6935/9839	97
WP2118	Arrhythmogenic right ventricular cardiomyopathy	44/3955	52/5488	0.025817685508606	0.404672753490822	0.384300212125151	60/87/81/488/775/776/781/9254/93589/782/783/1499/1674/1824/1829/1832/2010/2697/3672/22801/3673/3675/3676/3678/3655/3679/8516/3680/3685/3688/3690/3691/3693/3694/3696/3728/3908/4000/6443/6444/6546/6932/83439/6934	44
WP619	Type II interferon signaling	29/3955	33/5488	0.0266087925997198	0.404672753490822	0.384300212125151	4261/3627/4283/1536/5610/2633/3106/3383/2537/3433/3459/3553/3659/3662/10379/9636/3717/4843/4938/5580/5698/5781/5967/8651/9021/6688/6772/6773/6890	29
WP4823	Genes controlling nephrogenesis	25/3955	28/5488	0.0266632025740016	0.404672753490822	0.384300212125151	23607/948/1499/6387/2118/2263/2737/6928/3611/3675/8516/3688/3791/3913/4690/8440/4853/5155/5159/5979/6092/6469/6943/7422/54361	25
WP4842	Mammalian disorder of sexual development	11/3955	11/5488	0.0271248041289138	0.404672753490822	0.384300212125151	1499/2254/2263/5600/5087/5730/23543/30812/6662/6715/54361	11
WP3995	Prion disease pathway	28/3955	32/5488	0.0329240754845476	0.444935510017252	0.422536010657116	10538/53335/596/836/1385/10664/1879/2002/2033/2260/2534/7184/3309/3662/5595/4208/4684/4790/5079/2923/5452/5621/5993/6256/9126/6688/6774/6908	28
WP4216	Chromosomal and microsatellite instability in colorectal cancer 	56/3955	68/5488	0.034467190227909	0.444935510017252	0.422536010657116	207/10000/324/26060/369/8312/8313/572/578/27113/596/10018/332/673/836/842/595/1026/1499/1643/55770/2353/1647/4616/10912/5604/5602/5595/5599/5601/4292/4436/4437/2956/4609/9423/5366/51426/5743/5879/5894/5898/5899/5900/5966/387/4088/4089/29110/6932/83439/6934/7040/7043/7046/7048	56
WP5176	Disorders of bile acid synthesis and biliary transport	10/3955	10/5488	0.0376653173683624	0.444935510017252	0.422536010657116	5244/1244/8309/5205/1593/9420/3295/80270/6342/11001	10
WP3967	miR-509-3p alteration of YAP1/ECM axis	15/3955	16/5488	0.0379218713867823	0.444935510017252	0.422536010657116	9564/1277/1281/1289/1909/2335/10082/5090/6591/6678/7003/8463/7004/7058/10413	15
WP530	Cytokines and inflammatory response	15/3955	16/5488	0.0379218713867823	0.444935510017252	0.422536010657116	920/1435/1440/2919/2920/3122/3123/3589/3600/3552/3553/3569/5154/7040/7124	15
WP474	Endochondral ossification	45/3955	54/5488	0.0395280596689196	0.444935510017252	0.422536010657116	9510/9507/11096/207/249/654/655/657/51719/1028/50515/1280/4921/5167/2247/2260/2261/2690/2737/9759/3157/3479/3481/3549/4208/4256/4322/4318/5327/5328/5566/860/85477/871/54407/6660/55553/6662/6696/6772/6777/7040/7067/7078/7422	45
WP4808	Endochondral ossification with skeletal dysplasias	45/3955	54/5488	0.0395280596689196	0.444935510017252	0.422536010657116	9510/9507/11096/207/249/654/655/657/51719/1028/50515/1280/4921/5167/2247/2260/2261/2690/2737/9759/3157/3479/3481/3549/4208/4256/4322/4318/5327/5328/5566/860/85477/871/54407/6660/55553/6662/6696/6772/6777/7040/7067/7078/7422	45
WP5090	Complement system in neuronal development and plasticity	68/3955	84/5488	0.0402552294857096	0.444935510017252	0.422536010657116	57194/23250/286410/5205/57198/558/578/637/712/713/714/715/716/717/719/720/721/722/725/727/728/729/10487/843/836/841/842/4179/1604/966/629/1675/3075/3426/5199/1191/1378/1380/286204/6376/56616/9787/355/356/2219/3684/3685/3687/3689/3690/3993/2011/4140/5648/4155/10461/4240/84612/84552/5359/57088/5590/5627/23513/710/7040/7043/7301	68
WP129	Matrix metalloproteinases	19/3955	21/5488	0.0415876555882175	0.444935510017252	0.422536010657116	682/4312/4319/4321/4322/4323/4324/4327/4313/10893/64386/79148/4314/4316/4318/7076/7077/7078/7124	19
WP2865	IL1 and megakaryocytes in obesity	19/3955	21/5488	0.0415876555882175	0.444935510017252	0.422536010657116	6347/2149/1839/3383/3606/3553/3554/3654/4318/4790/114548/5290/7941/6280/8991/7076/7077/7096/7097	19
WP4941	GPR143 in melanocytes and retinal pigment epithelium cells	19/3955	21/5488	0.0415876555882175	0.444935510017252	0.422536010657116	196883/115/408/409/1385/2769/2776/3708/4286/23236/5330/5331/5332/6490/5566/5567/5176/7306/7422	19
WP1422	Sphingolipid pathway	23/3955	26/5488	0.0419142147117701	0.444935510017252	0.422536010657116	427/56624/9331/64781/29956/79603/91012/253782/9514/57704/2531/5499/57515/259230/166929/8879/130367/8877/56848/9517/55304/7357/7368	23
WP4545	Oxysterols derived from cholesterol	23/3955	26/5488	0.0419142147117701	0.444935510017252	0.422536010657116	26027/55856/10965/122970/11332/10005/23597/8309/9023/1593/1576/9420/1628/1717/10682/2053/80270/3638/7376/8856/6097/6342/11001	23
WP4559	Interactions between immune cells and microRNAs in tumor microenvironment	23/3955	26/5488	0.0419142147117701	0.444935510017252	0.422536010657116	6347/29126/941/942/1493/3627/3559/3560/3561/3566/4790/4791/5133/10401/8651/6774/6778/7040/7043/7048/7099/51311/7189	23
WP5088	Prostaglandin signaling	23/3955	26/5488	0.0419142147117701	0.444935510017252	0.422536010657116	196/834/6347/6348/729230/1435/2919/3627/4283/3552/3553/3569/3665/4318/4790/114548/5294/5732/5734/9536/7040/7124/7422	23
WP4217	Ebola virus infection in host	95/3955	120/5488	0.0465404931977214	0.477977096243457	0.453914176066441	60/87/81/6868/207/558/684/708/857/858/30835/11314/998/10462/8218/1387/1508/1514/153090/1956/5610/1965/2033/2060/2316/2317/2318/26762/84868/3105/3106/3107/3108/3109/3111/3112/3113/3115/3117/3118/3119/3120/3122/3123/3133/3134/3135/3384/3385/9641/8826/3665/3672/3673/3675/3676/3678/3655/3685/3688/3690/5595/10461/4240/4790/4791/10577/5058/5290/5291/5295/5296/8503/5868/9367/5879/5966/5970/5981/387/388/389/85477/9021/6772/29110/91937/7099/7150/219931/7301/7410/23339/27072/27183	95
WP1533	Vitamin B12 metabolism	30/3955	35/5488	0.0467586289803382	0.477977096243457	0.453914176066441	19/338/348/875/6347/1491/8029/3043/3383/3553/3569/3643/3949/84693/4524/4790/4791/5327/5970/6288/6289/949/5054/6472/6647/6648/6649/6947/6948/7124	30
WP4963	p53 transcriptional gene network	63/3955	78/5488	0.0512438176068071	0.512732318099699	0.486919707119851	136/84335/8659/6790/27113/7832/6347/898/900/993/1017/1026/6376/1643/54541/64798/55332/144455/2176/355/356/1647/2876/3383/3663/10379/9636/3976/406937/4292/4436/4688/64065/5366/5371/5429/51426/5564/5565/5571/51422/5728/57521/50484/6303/5268/5054/27244/83667/2810/23657/7057/7124/8795/8793/94241/9618/7249/8408/9706/7508/7520/64393	63
WP98	Prostaglandin synthesis and regulation	33/3955	39/5488	0.0520606955390332	0.512732318099699	0.486919707119851	10257/231/1645/301/302/306/307/308/309/873/1906/1909/1910/3248/27306/3290/3291/4286/5321/5468/10891/133522/5729/5730/5732/5734/9536/5737/5742/5743/6277/6662/6916	33
WP5064	7-oxo-C and 7-beta-HC pathways	18/3955	20/5488	0.0529451850211645	0.512732318099699	0.486919707119851	26027/55856/10965/122970/11332/10005/23597/8309/1593/1628/1717/10682/2053/3290/3291/10577/6342/11001	18
WP4541	Hippo-Merlin signaling dysregulation	75/3955	94/5488	0.0552800607294844	0.526113681425438	0.499627409133997	84962/154796/595/960/999/1009/1012/1015/28513/64403/1001/1003/1004/1436/1499/3627/1956/1969/2260/2263/2261/2321/2322/2324/2305/3643/3672/22801/3673/3675/3676/3678/3655/3679/8516/3680/3682/3684/3685/3687/3688/3689/3690/3691/3693/3694/3696/3791/3815/26524/4485/4609/4804/4893/4915/5058/5062/10298/5156/5159/5332/5499/5501/5566/5567/5573/5575/5577/9978/60485/6788/7003/8463/7004/7010	75
WP2880	Glucocorticoid receptor pathway	49/3955	60/5488	0.0598264092589901	0.540631280069931	0.513414144688836	11057/11214/241/221079/84002/8553/329/330/6347/6364/1028/80315/8454/1907/8507/54566/121512/9982/4616/387509/3320/3589/56262/4240/8972/4791/8856/2908/5142/10769/5460/79056/5743/5997/6256/6337/6397/5272/9792/1836/6591/10252/5552/2040/7049/7056/7128/84951/1831	49
WP3945	TYROBP causal network in microglia	49/3955	60/5488	0.0598264092589901	0.540631280069931	0.513414144688836	10257/55803/51411/714/822/951/920/8832/58191/1806/2000/23307/79690/202309/2876/3142/10261/3587/3597/3606/3684/3687/3689/10008/284194/10184/84695/4066/4094/4688/10577/375387/5341/170954/54502/6039/6195/64092/375035/10019/6510/9056/6696/6776/10312/7046/113277/7133/7305	49
WP3611	Photodynamic therapy-induced AP-1 survival signaling	39/3955	47/5488	0.0605123736184841	0.540631280069931	0.513414144688836	1386/578/596/598/10018/602/637/90427/890/595/898/1026/8837/1956/2002/355/356/2252/2353/1839/3320/3569/3726/5606/5608/5609/4217/5600/6300/5603/5599/4170/4313/5156/5925/7124/7132/7188/7189	39
WP428	Wnt signaling	68/3955	85/5488	0.0607230785585792	0.540631280069931	0.513414144688836	324/8312/818/595/894/1454/1457/1459/283106/1460/1488/1499/56998/80319/23002/23500/1855/1856/10023/23401/7976/7855/8323/8324/8325/2239/27130/83999/4041/4040/5599/5601/4609/4772/4773/4775/4776/51701/5328/23236/5330/5331/5332/64840/5530/5532/144165/166336/5879/387/9475/4919/4920/6259/59343/5176/6422/6423/6425/6932/83439/6934/57216/7482/7473/54361/7474/81029	68
WP306	Focal adhesion	134/3955	173/5488	0.0621136594569716	0.544233968575371	0.516835462148235	60/87/81/207/10000/2909/394/572/9564/596/329/330/640/673/857/858/595/894/998/1101/1277/1278/1280/1282/1284/1290/50509/1292/1399/1499/1793/1956/2002/2064/2268/2316/2317/2318/2321/2335/2534/3055/3082/3479/3611/3672/22801/3673/3675/3676/3678/3655/3679/8516/3680/3685/3688/3690/3691/3693/3694/3696/3791/284217/3908/3910/3911/3912/3913/3914/3915/3918/10319/5604/5602/5595/5599/5601/4636/10398/4638/5058/5062/10298/55742/29780/5154/5155/80310/5156/5159/5170/5228/5290/5291/5295/5296/8503/23396/5499/5501/4660/54776/5728/5753/5879/5894/5908/5649/387/9475/6464/25759/6654/6696/6714/55359/10420/7057/7058/7059/7094/83660/3371/8711/7294/7408/7410/10451/7414/7422/7424/7450/7791	134
WP2840	Hair follicle development: cytodifferentiation - part 3 of 3	42/3955	51/5488	0.0638512216749462	0.550716786946411	0.522991914377026	6868/64919/654/657/947/1499/1523/27122/1824/1956/1959/2353/2354/2619/2625/2736/23560/55806/3479/3488/4254/3866/3880/8549/4772/4790/4853/2908/64065/22822/8842/3516/6275/6422/4086/4089/25928/6662/11005/6929/7040/7474	42
WP4150	Wnt signaling in kidney disease	21/3955	24/5488	0.0649152296664771	0.551280104244544	0.523526872451913	1499/1855/1856/7976/8322/7855/8323/8324/8325/27130/4041/4040/5602/5599/5601/387/7482/7473/54361/7474/81029	21
WP170	Nuclear receptors	24/3955	28/5488	0.0744390096800699	0.570305478236436	0.541594447295471	2101/3172/9975/7376/8856/7182/7025/7026/2063/2908/2494/5465/5467/5468/5914/5916/4919/6095/6097/6256/6257/7067/7068/7421	24
WP4786	Type I collagen synthesis in the context of osteogenesis imperfecta	24/3955	28/5488	0.0744390096800699	0.570305478236436	0.541594447295471	9509/649/1277/1278/79709/90993/10491/60681/3708/4015/4041/4040/51360/5033/5034/5351/5352/5479/5176/871/55151/8792/4982/8600	24
WP4673	Male infertility	72/3955	91/5488	0.0787520424561078	0.570305478236436	0.541594447295471	5243/3983/27161/196/338/406/472/596/675/847/8812/905/9575/1191/1387/30827/56603/11218/2033/94240/2068/2119/355/356/2346/2775/2876/3122/3643/55818/222229/4193/4292/27030/4313/4318/4522/4524/4843/4846/1728/142/10400/55124/143689/5395/5423/5428/5445/55170/29968/23369/5896/9985/5981/8787/140885/9194/113235/6648/6649/6660/6948/7057/7124/9319/23304/7508/7517/7518/7520/51087	72
WP4172	PI3K-Akt signaling pathway	197/3955	259/5488	0.0796839237432511	0.570305478236436	0.541594447295471	207/10000/284/285/1386/468/572/596/598/10018/842/595/894/898/9134/930/11140/1017/1019/1021/1026/1101/1147/1277/1278/1280/1282/1284/1285/1291/1292/1293/1298/1385/10488/90993/84699/148327/9586/1435/1436/1440/1441/54541/1942/1944/1945/1946/1956/1975/1977/1978/1969/2149/356/2258/2247/2252/2254/2260/2263/2261/2321/2322/2324/2335/92579/2690/2782/2783/59345/2791/55970/2786/2787/3082/3320/7184/3454/3455/3479/3481/8517/3559/3560/3561/3563/3566/3569/3575/3643/3667/3672/22801/3673/3675/3676/3678/3655/3679/8516/3680/3685/3688/3690/3691/3693/3694/3696/3717/3791/3815/4254/284217/3908/3910/3911/3912/3913/3914/3915/3918/10319/57121/10161/5604/5605/5595/4170/4193/4609/4790/4804/4846/4893/4915/5008/9180/5105/5106/5154/5155/80310/5156/5159/5170/5228/23239/23035/5290/5291/5294/5295/5296/8503/23533/5586/29941/5519/55844/5523/28227/5525/5526/5528/5529/5618/5728/5879/5894/5934/5970/5649/6009/6194/6198/57521/6446/10110/6654/6655/6696/6850/8115/7010/7039/7057/7058/7059/7097/7099/3371/7248/7249/7422/7424/7450	197
WP4900	Purinergic signaling	20/3955	23/5488	0.0802844522058707	0.570305478236436	0.541594447295471	136/2770/2771/2773/2775/10161/5023/5025/5026/5027/5028/5032/64805/53829/9934/5029/5030/5031/286530/24145	20
WP5183	SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction	20/3955	23/5488	0.0802844522058707	0.570305478236436	0.541594447295471	28976/1636/59272/51295/3606/3569/57506/54602/51103/91942/4790/114548/27035/6195/51548/7014/54386/7124/7187/7189	20
WP4222	Phosphodiesterases in neuronal function	27/3955	32/5488	0.0820469439035586	0.570305478236436	0.541594447295471	107/196883/111/112/113/115/1139/1385/2977/10846/50940/201626/5136/5153/5137/5138/5139/5140/5141/5142/5144/5145/5150/27115/5151/8622/5152	27
WP465	Tryptophan metabolism	27/3955	32/5488	0.0820469439035586	0.570305478236436	0.541594447295471	51166/38/125061/8854/224/223/26/316/847/1545/1573/1576/66002/9420/1644/1892/2639/23498/3028/3620/11185/8942/4129/4967/3276/6999/7166	27
WP4566	Translation inhibitors in chronically activated PDGFRA cells	37/3955	45/5488	0.0831878738725458	0.570305478236436	0.541594447295471	207/10000/1457/1974/1975/1977/1978/1981/8672/5604/5605/5606/5607/5608/5609/5602/5595/5599/5601/27250/5163/5290/5291/5294/5295/5296/8503/5292/11040/5566/5580/6194/6195/6196/8986/6198/57521	37
WP3670	Interactions between LOXL4 and oxidative stress pathway	16/3955	18/5488	0.0847701388350333	0.570305478236436	0.541594447295471	308/650/11140/1280/780/51295/54536/2252/2335/3490/84171/1728/4899/23411/6839/7040	16
WP383	Striated muscle contraction pathway	16/3955	18/5488	0.0847701388350333	0.570305478236436	0.541594447295471	59/81/1674/4604/4621/10398/8736/7111/7134/7125/7168/7169/7170/7171/7273/7431	16
WP4142	Metabolism of spingolipids in ER and Golgi apparatus	16/3955	18/5488	0.0847701388350333	0.570305478236436	0.541594447295471	8706/8708/8707/2683/8704/64781/2531/166929/8879/81537/130367/8877/56848/256435/7357/7368	16
WP4722	Glycerolipids and glycerophospholipids	16/3955	18/5488	0.0847701388350333	0.570305478236436	0.541594447295471	56895/10423/1040/56994/54675/8694/8525/55500/57678/5833/10400/23761/5337/57104/9791/81490	16
WP5044	Kynurenine pathway and links to cell senescence	16/3955	18/5488	0.0847701388350333	0.570305478236436	0.541594447295471	51166/125061/196/1026/440275/2308/23498/3620/7850/688/8564/8942/23475/6999/7099/7124	16
WP5181	Roles of ceramides in the development of insulin resistance	16/3955	18/5488	0.0847701388350333	0.570305478236436	0.541594447295471	2180/207/948/5610/2081/3643/3667/8660/5599/5295/5590/6198/55512/7124/7132/7185	16
WP3958	GPR40 pathway	12/3955	13/5488	0.0851502921676867	0.570305478236436	0.541594447295471	2767/3710/23236/5330/5331/5333/113026/51196/5335/5336/23007/5334	12
WP4210	Tryptophan catabolism leading to NAD+ production	12/3955	13/5488	0.0851502921676867	0.570305478236436	0.541594447295471	51166/125061/23498/3620/8564/8942/10135/64802/349565/54981/23475/6999	12
WP2034	Leptin signaling pathway	59/3955	74/5488	0.0857524541551162	0.570305478236436	0.541594447295471	31/32/207/572/598/595/998/1073/1147/1154/1385/1977/1978/2002/2064/2308/2534/2931/8517/3553/3557/3667/3717/10657/3953/5604/5605/5595/5599/8648/4790/4846/5140/5295/5296/5335/5336/5728/5770/5781/5879/5894/5966/5970/387/9475/6194/6195/6198/25970/6464/8835/9021/30837/6654/6714/6772/6774/6777	59
WP4263	Pancreatic adenocarcinoma pathway	65/3955	82/5488	0.0873223144656537	0.573832352202867	0.544943766966109	207/10000/369/572/578/598/673/675/842/595/998/1019/1021/1026/1147/1643/1848/1870/1871/1956/2064/1647/4616/10912/8517/5604/5605/5602/5595/5599/5601/4790/5058/5062/10298/5037/5290/5291/5295/5296/8503/5337/51426/5580/5879/5894/5898/5899/10928/5900/5925/5970/387/54101/6198/4088/4089/6772/6774/7039/7040/7043/7046/7048/7422	65
WP24	Peptide GPCRs	23/3955	27/5488	0.0903631215239541	0.58000515210724	0.550805808065228	10396/624/719/728/1230/729230/1234/10803/3577/3579/2833/643/10663/1909/1910/2357/2358/2359/4886/5540/4888/6751/6752	23
WP2533	Glycerophospholipid biosynthetic pathway	23/3955	27/5488	0.0903631215239541	0.58000515210724	0.550805808065228	8540/10423/10390/56994/54675/8443/57678/150763/2819/253430/23175/346606/5833/10400/9489/55361/5290/5291/5294/8394/5320/9791/114971	23
WP2064	Neural crest differentiation	46/3955	57/5488	0.0915152962552198	0.580648776240015	0.551417030067749	8312/8313/655/999/1004/1280/1488/1499/28514/54567/1855/1856/2247/2260/2263/2261/7976/2705/79885/3066/9759/10014/10013/51564/55869/9734/3198/3397/3688/4155/4286/4359/4609/4790/4791/4853/4854/4855/5376/3516/388/4086/6591/6660/6662/83439	46
WP4482	Vitamin D in inflammatory diseases	19/3955	22/5488	0.0988406560715888	0.613034181477719	0.582172048771747	1147/1843/8517/3569/5606/5608/4214/9282/4772/4790/4792/2908/5530/5970/6256/4088/4089/7124/7421	19
WP4969	RAS and bradykinin pathways in COVID-19	19/3955	22/5488	0.0988406560715888	0.613034181477719	0.582172048771747	1636/59272/624/1576/2161/3552/3553/3816/3818/3827/4790/4846/4881/5592/387/5054/710/7124/7421	19
WP3874	Canonical and non-canonical TGF-B signaling	15/3955	17/5488	0.106528942805119	0.645854353743182	0.613339946918583	649/657/659/26585/4015/4016/4017/84171/5599/5601/4088/4089/7040/7046/7048	15
WP706	Sudden infant death syndrome (SIDS) susceptibility pathways	81/3955	104/5488	0.10859575063547	0.645854353743182	0.613339946918583	34/8553/720/721/836/54862/55536/1051/1139/1374/1385/1387/1390/10664/1499/1644/10522/1958/2033/54738/2305/2597/2624/2625/2697/23171/3030/3032/9734/3091/7184/3552/3553/3557/3569/3757/3764/3784/4128/4152/4204/4208/4760/4790/4791/2908/4915/5087/5316/5354/5452/5460/10891/133522/5566/5567/5573/5575/5577/5978/5979/6095/6507/291/6532/6550/6640/6751/6752/6929/7068/7124/7166/11076/7259/6844/7422/7433/7531/7532/7534	81
WP2848	Pluripotent stem cell differentiation pathway	22/3955	26/5488	0.109198203780712	0.645854353743182	0.613339946918583	1435/1436/3577/2247/3082/3479/3589/3569/3624/3815/4254/10637/4907/5154/5155/6469/7040/7043/8600/7422/7482/7474	22
WP3869	Cannabinoid receptor signaling	22/3955	26/5488	0.109198203780712	0.645854353743182	0.613339946918583	107/113/196/1268/1269/1576/747/221955/2166/5602/5600/6300/5603/5595/5599/5601/222236/5566/5567/5573/5575/5577	22
WP75	Toll-like receptor signaling pathway	66/3955	84/5488	0.109982444296846	0.645854353743182	0.613339946918583	207/10000/841/6348/6351/929/958/941/942/1147/3627/6373/4283/2353/3454/3455/9641/8517/3553/3569/3654/3663/3665/23643/5604/5605/5606/5608/5609/1326/5602/5600/6300/5603/5595/5599/5601/4790/4792/5290/5291/5294/5295/5296/8503/23533/5879/5970/6696/6772/257397/29110/148022/114609/7096/7097/7098/7099/7100/10333/51311/54106/7124/54472/7187/7189	66
WP4718	Cholesterol metabolism with Bloch and Kandutsch-Russell pathways	35/3955	43/5488	0.112745511057912	0.655110758989131	0.622130354646429	19/9619/39/10965/2180/2181/2182/9023/1593/1595/1717/10682/60481/3992/9415/2194/2222/3156/3157/3158/51478/3422/4047/6307/4598/29116/7376/50814/10654/6309/6319/6646/8435/6713/6721	35
WP2380	Brain-derived neurotrophic factor (BDNF) signaling pathway	92/3955	119/5488	0.116472275936482	0.661236016175557	0.627947246482509	32/6868/207/249/324/572/10018/650/8536/814/836/998/1020/8851/1147/1268/1385/23373/1457/1499/1739/1808/1938/1958/1959/1965/8894/1977/1978/2002/2353/10818/2534/23426/8517/3667/8660/3717/3738/57498/8844/5604/5605/5607/4214/10746/5602/5595/5599/5601/4082/4208/4684/4688/4690/8440/4776/4790/4792/4804/4905/4915/5170/5295/5296/5335/5580/2185/5781/5792/5879/5894/5970/391/6194/6195/6198/25970/6464/25759/140885/6272/6696/6714/6772/6774/6776/6777/7189/7249/7410/10451	92
WP5097	CCL18 signaling pathway	25/3955	30/5488	0.116938029162547	0.661236016175557	0.627947246482509	59/205/467/960/999/1278/2033/2335/8322/3091/3799/4313/4318/92140/4609/5728/2185/100505648/6772/7004/7412/7424/7431/81671/9839	25
WP4262	Breast cancer pathway	89/3955	115/5488	0.117393350697834	0.661236016175557	0.627947246482509	207/10000/324/369/472/545/8312/8313/578/673/675/595/1019/1021/1026/1070/1457/1459/283106/1460/1499/1643/28514/54567/1855/1856/1870/1871/1956/2064/2247/2252/2254/2260/2324/2353/10023/23401/7976/7855/8323/8324/8325/1647/4616/10912/23462/26508/3479/3714/3815/4041/4040/5604/5605/5595/4609/4683/8648/8202/4791/4853/4854/4855/4893/142/5290/5295/5296/8503/51426/5728/10111/5894/5925/6198/6464/25759/6654/6655/6932/83439/6934/8600/7482/7473/54361/7474/81029	89
WP3932	Focal adhesion: PI3K-Akt-mTOR-signaling pathway	184/3955	244/5488	0.131231461844618	0.731714817557869	0.69487791598745	31/207/84335/10000/284/285/1386/468/572/51719/81617/842/11140/1026/1101/1277/1278/1280/1281/1282/1284/1289/1290/50509/1292/1385/10488/90993/84699/148327/9586/1435/1436/1440/1441/54541/1942/1944/1945/1946/1956/1975/1977/1978/2034/1969/2149/2258/2247/2252/2254/2260/2263/2261/2321/2324/2335/3169/2308/2690/2782/2783/59345/2791/55970/2786/2787/3082/3091/3320/7184/3454/3455/3479/8517/3559/3560/3561/3563/3566/3575/3643/3667/8660/22801/3673/3675/3676/3678/3655/3679/8516/3680/3682/3685/3687/3688/3689/3690/3691/3693/3694/3696/3717/3791/3815/4254/284217/3908/3910/3911/3912/3913/3914/3915/3918/10319/3991/57121/10161/5604/5605/5595/4193/4804/4843/4846/4893/5008/9180/5154/5155/80310/5156/5159/5170/53918/5209/5210/5228/23239/23035/5286/5287/5290/5291/5294/5295/5296/23533/10891/5519/55844/5523/5525/5526/5528/5529/5618/5728/10890/4218/5894/5649/6009/6194/6198/57521/6514/6515/6654/6696/8115/7010/7057/7058/7059/3371/7248/7249/8408/7422/7424/7450	184
WP176	Folate metabolism	37/3955	46/5488	0.13299830818668	0.734150661190476	0.697191131336493	19/338/847/875/6347/1435/1491/1719/2350/2618/2876/2877/2878/2879/3043/3383/3553/3569/3643/3949/4522/10797/4524/4790/4791/5327/5970/6288/6289/949/5054/6472/113235/6647/6648/6649/7124	37
WP3888	VEGFA-VEGFR2 signaling pathway	299/3955	401/5488	0.135329604763646	0.736981623369581	0.699879573680494	31/32/23597/102/8754/9510/56999/154/207/84335/154796/301/1175/81575/378/382/22899/51309/81873/409/10973/1386/468/22926/9564/596/598/274/332/650/660/23476/682/56905/781/811/813/10645/832/857/6347/595/9034/10574/998/1003/84952/79094/1192/1267/22820/1385/1387/1397/1445/1465/1499/1500/1536/1558/54505/170506/54567/3301/11080/4189/1796/8813/1847/8411/1958/9451/8665/8667/1977/1981/2002/2022/2035/1969/2048/29924/2060/2078/2081/2130/7430/2152/10056/355/152273/2274/29109/2317/2321/2335/2308/4303/10818/6624/9513/2534/2549/2597/2624/26058/10755/2697/2817/2876/2887/1839/9759/10014/51564/9734/9709/3142/3320/3315/5654/10525/3383/3418/51278/3490/8821/51763/8826/83737/3685/3688/3690/3693/23189/3791/9365/9079/3984/3998/55379/9209/55692/5604/5605/5606/5608/5609/4217/6300/5595/5599/5601/9261/8550/4193/4208/9645/8569/4319/4323/4313/79812/4343/4629/4641/4673/4688/4690/4691/10397/91624/4772/4773/4790/4792/4846/4855/8013/441478/8828/100506658/4952/5034/5058/5062/55872/57326/10130/5170/5216/5226/5228/5230/5290/5295/5296/5321/5328/5329/5331/5335/8985/4860/5496/5499/5530/9588/5580/5581/5590/5587/5592/5717/5743/2185/5757/5770/5781/5784/5780/5795/9444/8766/326624/5867/5868/5879/5894/5908/9584/1827/5954/5970/387/389/57381/253260/27289/9475/4736/6154/6125/6129/6181/6194/6198/1901/57758/6386/23753/6401/80031/9047/83442/6461/6464/25759/357/6478/6541/6546/6595/27044/6648/56907/6714/6722/6729/6747/6748/8027/6772/6774/6778/10963/8867/6886/9344/7004/7086/124491/7111/29766/9168/8794/219931/7170/7220/7295/10628/9898/7410/7414/7422/23339/8936/7531/148254	299
WP3933	Kennedy pathway from sphingolipids	10/3955	11/5488	0.143070449762849	0.736981623369581	0.699879573680494	10390/1119/56994/55500/5833/10400/23761/9791/81490/8879	10
WP3971	OSX and miRNAs in tooth development	10/3955	11/5488	0.143070449762849	0.736981623369581	0.699879573680494	249/655/1499/6927/9314/406937/4853/4854/4855/860	10
WP4723	Omega-3 / omega-6 fatty acid synthesis	10/3955	11/5488	0.143070449762849	0.736981623369581	0.699879573680494	10965/51/2180/2181/2182/60481/3992/9415/5321/8398	10
WP554	ACE inhibitor pathway	10/3955	11/5488	0.143070449762849	0.736981623369581	0.699879573680494	1636/59272/10159/624/1215/1511/3827/4846/4306/7040	10
WP3850	Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling	27/3955	33/5488	0.143954723091447	0.736981623369581	0.699879573680494	93/207/84335/64798/8892/1977/114907/3479/3488/3611/3667/3688/51528/84557/4790/5163/5294/5337/10891/5564/5728/253260/6198/57521/4088/7132/8976	27
WP4321	Thermogenesis	72/3955	93/5488	0.147800644199817	0.736981623369581	0.699879573680494	2180/2181/2182/51703/23305/60/86/107/196883/111/112/113/115/84335/8289/57492/1386/656/1268/1374/1376/1385/10488/90993/84699/148327/9586/8110/2260/10818/55818/51780/152831/3991/5606/4217/5600/6300/5603/11343/4881/4893/57104/5468/10891/5564/5565/5566/5567/5571/51422/5592/5593/6009/6194/6195/6196/27330/6198/57521/51548/123096/6595/6597/6598/6601/6602/6604/6654/6655/7248/7249	72
WP185	Integrin-mediated cell adhesion	66/3955	85/5488	0.150181187272381	0.736981623369581	0.699879573680494	207/10000/369/8874/9564/673/726/827/23473/10753/826/857/858/998/1445/1793/2534/3611/3672/22801/3673/3675/3676/3678/3655/3679/8516/3680/3682/3684/3685/3687/3688/3689/3690/3691/3693/3694/3696/5604/5605/5606/5607/5608/5602/6300/5597/5058/5062/10298/5170/5296/5879/5894/5908/9475/6464/6654/6714/7094/7145/7408/7410/10451/7414/7791	66
WP2332	Interleukin-11 signaling pathway	33/3955	41/5488	0.150491261786358	0.736981623369581	0.699879573680494	207/466/596/332/1147/1385/2242/2534/3383/3589/3572/3673/3717/5604/5605/5595/5170/10401/5295/5296/5781/5894/5970/6194/6195/6198/860/9021/6714/6772/6774/7040/7525	33
WP4747	Netrin-UNC5B signaling pathway	36/3955	45/5488	0.152368326531855	0.736981623369581	0.699879573680494	207/249/23365/836/6347/1003/1277/1612/2534/3383/3552/3691/3791/5604/5605/5595/4756/9423/5290/57475/5499/5519/2185/5781/5879/5894/56963/387/6018/54538/6401/6714/7124/219699/7412/10413	36
WP5053	Development of ureteric collection system	36/3955	45/5488	0.152368326531855	0.736981623369581	0.699879573680494	650/655/168667/657/659/595/51232/23399/1499/2118/79633/2263/80144/158326/2625/10220/2674/2736/2737/23426/6928/3611/8516/3688/5087/5914/5916/5979/6091/6092/6299/6469/4086/6608/10252/57216	36
WP4336	ncRNAs involved in Wnt signaling in hepatocellular carcinoma	48/3955	61/5488	0.154575983299823	0.736981623369581	0.699879573680494	324/8312/595/894/1454/1457/1459/283106/1460/1488/1499/56998/80319/1855/1856/10023/23401/7976/7855/8323/8324/8325/9314/83999/4041/4040/92140/4609/51701/5328/64840/4919/4920/6259/59343/5176/6422/6423/6425/83595/6932/83439/6934/7482/7473/54361/7474/81029	48
WP1539	Angiogenesis	20/3955	24/5488	0.157130564902839	0.736981623369581	0.699879573680494	207/284/1387/2247/2263/2321/3091/3791/4318/4846/5155/5156/5290/5335/4086/6714/7010/7077/7078/7422	20
WP3613	Photodynamic therapy-induced unfolded protein response	20/3955	24/5488	0.157130564902839	0.736981623369581	0.699879573680494	440/467/468/22926/27113/10018/811/51726/4189/5611/9695/9451/2081/7184/3309/10130/23645/57761/7324/7494	20
WP4698	Vitamin D-sensitive calcium signaling in depression	20/3955	24/5488	0.157130564902839	0.736981623369581	0.699879573680494	490/493/596/775/1593/1594/2539/2729/2678/2879/2936/3708/3710/3786/221656/55818/6256/6546/7166/7421	20
WP581	EPO receptor signaling	20/3955	24/5488	0.157130564902839	0.736981623369581	0.699879573680494	207/1154/3667/8660/3717/5604/5605/5595/5163/5294/10076/5894/6464/8651/6654/6714/6772/6774/6776/6777	20
WP5083	Neuroinflammation and glutamatergic signaling	77/3955	100/5488	0.159252234862816	0.736981623369581	0.699879573680494	107/207/596/818/814/84254/10645/1385/1610/27185/1737/2247/2353/2744/2752/2805/2893/116443/2918/3459/3479/3587/3597/3552/3553/3554/7850/3566/3569/3572/3643/3667/3976/56262/23507/84230/55144/80131/4049/5595/4790/4791/26012/23236/5330/5331/5332/5499/5501/5566/29968/6472/6505/6506/6507/6509/6515/54407/92745/4088/4089/4092/9021/63826/6772/6774/6778/7040/7043/7046/7048/7049/7124/7132/7133/7188/54795	77
WP1601	Fluoropyrimidine activity	23/3955	28/5488	0.163614036005822	0.736981623369581	0.699879573680494	10257/9429/978/1066/8824/1719/1806/2068/2356/4524/5471/6240/6241/2030/23583/6996/7083/1890/7298/83549/7371/7378/7517	23
WP4481	Resistin as a regulator of inflammation	23/3955	28/5488	0.163614036005822	0.736981623369581	0.699879573680494	207/10000/1147/8517/3569/3708/5595/4790/4792/5290/5291/5294/23236/5330/5331/5332/5333/113026/51196/5335/5336/5970/7124	23
WP197	Cholesterol biosynthesis pathway	13/3955	15/5488	0.165553842930848	0.736981623369581	0.699879573680494	1595/1717/2222/3156/3157/3422/4047/6307/4598/50814/10654/6309/6713	13
WP3859	TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition	13/3955	15/5488	0.165553842930848	0.736981623369581	0.699879573680494	207/999/1004/2335/3397/5595/860/4088/4089/6591/7040/3371/7431	13
WP4462	Platelet-mediated interactions with vascular and circulating cells	13/3955	15/5488	0.165553842930848	0.736981623369581	0.699879573680494	6347/958/959/3383/3553/6401/6403/6404/7040/7043/7097/7099/7412	13
WP4970	Galanin receptor pathway	13/3955	15/5488	0.165553842930848	0.736981623369581	0.699879573680494	10018/1026/1028/1385/2353/3569/3880/5468/10891/5580/6844/7422/10413	13
WP516	Hypertrophy model	13/3955	15/5488	0.165553842930848	0.736981623369581	0.699879573680494	102/467/11072/1977/1978/1839/3475/3606/3552/3554/8013/7422/6935	13
WP4331	Neovascularisation processes	29/3955	36/5488	0.170948740151831	0.747424696710169	0.709796908775103	94/207/284/6387/54567/2048/2050/2324/3091/3791/3815/4254/5595/5599/5601/4318/4790/4791/4854/4855/5155/5966/5970/4086/4088/4090/7040/7043/7046	29
WP4877	Host-pathogen interaction of human coronaviruses - MAPK signaling	29/3955	36/5488	0.170948740151831	0.747424696710169	0.709796908775103	1386/596/684/1977/2353/3429/8519/10581/10410/3726/5604/5605/5606/5608/5609/4214/4296/4216/4293/5602/5600/6300/5603/5595/5599/5601/5894/6195/6196	29
WP3941	Oxidative damage response	32/3955	40/5488	0.172814887069548	0.747424696710169	0.709796908775103	572/9530/578/596/712/713/714/715/716/717/719/721/727/728/836/842/998/1026/1028/1380/1647/4214/4293/5602/5603/4790/51567/7124/7133/7185/7187/7189	32
WP2572	Primary focal segmental glomerulosclerosis (FSGS)	47/3955	60/5488	0.173315871700909	0.747424696710169	0.709796908775103	81/375790/207/977/23607/941/1026/1028/9076/1285/1378/1499/1514/1759/2195/2534/3611/64423/3664/3675/3685/3688/3690/3691/3911/3913/3987/4041/4040/4311/4643/4690/55742/5329/51196/5335/5420/5800/950/11346/7040/7094/7099/7225/7402/7414/7431	47
WP4754	IL-18 signaling pathway	171/3955	228/5488	0.175714327814452	0.750583912799531	0.712797079660882	32/35/59/11096/57679/8125/321/382/55738/84364/467/567/572/596/598/637/274/330/650/669/682/7832/770/836/841/26093/6362/6363/6347/6364/6348/6351/890/948/975/1051/1059/8837/1147/9076/9069/24146/1365/1364/1277/1278/1281/1374/1499/58191/2920/2921/1674/1891/1938/2023/2035/2059/355/356/55294/2335/2353/1112/2896/338442/3162/3234/3257/3315/3383/8870/3606/10068/8809/8807/3553/3559/3569/3654/3659/3664/81618/3757/4254/23395/3932/84823/5609/5595/5601/56257/4312/4322/4323/4313/4314/4318/29781/4688/4717/4776/4790/4791/4792/64332/4843/27035/8431/51299/26012/142/51604/5295/7941/5335/5337/8985/5580/5728/5743/5778/5806/5834/5905/22821/5966/5970/5993/6004/6198/57521/860/23623/6257/8698/10500/80031/9497/6641/9021/10418/6696/83931/3925/30009/7052/7076/7078/55858/7124/7127/7128/4982/7132/8600/79931/10452/7185/7189/54822/10194/83549/56886/7422/51341/80149/55625/7702/51222/55311	171
WP4658	Small cell lung cancer	70/3955	91/5488	0.178500724924025	0.750583912799531	0.712797079660882	207/10000/578/596/598/637/329/330/836/841/842/595/898/9134/1017/1019/1021/1026/1028/1030/1147/1163/1164/1282/1284/1285/1643/1870/1871/2335/1647/4616/10912/8517/3673/3675/3655/3685/3688/284217/3908/3910/3911/3912/3913/3914/3915/3918/10319/4609/4790/4792/4843/5290/5291/5295/5296/8503/51426/5728/5743/5925/5970/6256/6257/7185/7187/9618/7188/7189	70
WP3657	Hematopoietic stem cell gene regulation by GABP alpha/beta complex	16/3955	19/5488	0.178806359283445	0.750583912799531	0.712797079660882	472/596/598/1387/2033/2120/2322/2551/2553/3002/4170/5728/4089/6597/7014/7543	16
WP4589	Major receptors targeted by epinephrine and norepinephrine	9/3955	10/5488	0.183993070854677	0.750583912799531	0.712797079660882	107/196883/111/112/113/115/150/153/154	9
WP4846	SARS-CoV-2 and COVID-19 pathway	9/3955	10/5488	0.183993070854677	0.750583912799531	0.712797079660882	38/59272/1514/5045/8829/949/340024/7113/56649	9
WP5188	Retinol metabolism	9/3955	10/5488	0.183993070854677	0.750583912799531	0.712797079660882	316/1551/10901/317749/10170/9227/8228/112724/195814	9
WP2037	Prolactin signaling pathway	58/3955	75/5488	0.186641409134988	0.750583912799531	0.712797079660882	207/836/1154/1509/1978/2002/2064/2316/2353/2534/3659/3667/8660/3688/3717/5604/5605/5595/5599/5601/4609/4752/4790/4792/4843/5058/10401/5290/5291/5294/5295/5296/5478/5479/5618/5770/5781/5879/5894/5970/6194/6196/6198/6464/140885/8651/8835/9021/6654/6714/6772/6774/6776/6777/7006/7410/7532/7534	58
WP3982	miRNA regulation of p53 pathway in prostate cancer	19/3955	23/5488	0.186982624433749	0.750583912799531	0.712797079660882	472/27113/637/836/841/842/11200/192668/1643/9538/4193/64065/5366/5728/5054/143686/51246/8795/64393	19
WP382	MAPK signaling pathway	145/3955	193/5488	0.189025847233812	0.750583912799531	0.712797079660882	207/10000/369/408/409/1386/468/673/773/775/776/8912/781/9254/93589/782/783/836/929/994/998/1147/1399/1616/1843/80824/1844/1846/1848/1849/1850/51295/1956/2002/355/356/2258/2247/2252/2254/2260/2263/2261/2316/2317/2318/2353/1647/2768/55970/3304/3305/3310/3315/8517/3552/3553/3554/7850/120892/5604/5605/5606/5607/5608/5609/4214/4296/7786/9175/9020/10746/4216/4217/9064/1326/11184/5871/9448/5602/5600/6300/5603/5595/5599/9479/23162/5601/9261/7867/8550/4208/8569/2872/22808/4609/4763/4772/4775/4790/4791/51701/4893/4915/5058/5062/5154/5155/5159/5321/8605/255189/5494/5530/5532/5566/5567/5580/5778/5801/5879/5894/5908/9693/5924/25780/115727/5970/8986/6237/22800/6654/6655/6722/6788/3925/9344/51347/7040/7043/7046/7048/7124/7132/7189	145
WP4008	NO/cGMP/PKG mediated neuroprotection	22/3955	27/5488	0.192072565710447	0.750583912799531	0.712797079660882	10142/572/596/818/842/1259/1385/1742/2977/3553/4790/4792/4843/4846/4881/5138/5139/5481/5593/5970/7124/706	22
WP5113	Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway	22/3955	27/5488	0.192072565710447	0.750583912799531	0.712797079660882	59272/6347/1147/2729/2939/2977/3162/8517/3553/3569/4312/4314/4790/4792/27035/1728/5593/5970/6256/23657/7113/7124	22
WP4155	Endometrial cancer	46/3955	59/5488	0.193699794994725	0.750583912799531	0.712797079660882	207/10000/324/369/8312/8313/572/578/673/842/595/999/1026/1499/1643/1956/2002/2064/2247/2260/2263/2261/2353/1647/4616/10912/3611/5604/5605/5595/4609/4893/5170/5290/5291/5295/5296/8503/51426/5728/5894/6654/6655/6932/83439/6934	46
WP15	Selenium micronutrient network	43/3955	55/5488	0.195108539633404	0.750583912799531	0.712797079660882	19/241/338/847/875/6347/1491/1734/2678/2876/2877/2878/2879/2936/3043/3383/3553/3569/3643/8564/8942/3949/51734/4524/4790/4791/5327/5052/10549/5742/5743/5970/6288/6289/949/22928/5054/6647/6648/6649/7124/7295/114112	43
WP61	Notch signaling pathway	43/3955	55/5488	0.195108539633404	0.750583912799531	0.712797079660882	6868/207/83464/595/1026/9541/8454/28514/54567/1840/2033/55294/2273/2625/3066/55502/23462/3091/83737/3714/3717/3932/9794/84441/55534/4609/9611/4790/4853/4854/4855/9253/5295/5296/5663/5664/55851/3516/8819/23013/6714/6774/7088	43
WP4816	TGF-beta receptor signaling in skeletal dysplasias	40/3955	51/5488	0.196286495535087	0.750583912799531	0.712797079660882	81794/25805/1387/1499/2022/2033/2200/2280/2353/3624/3694/10637/3976/4052/4054/5595/5601/4790/860/5054/6497/4086/4088/4089/4090/4092/6696/6772/6774/7030/7040/7046/7048/7049/7050/7057/7124/9839/9372/23090	40
WP3940	One-carbon metabolism and related pathways	28/3955	35/5488	0.196867006837202	0.750583912799531	0.712797079660882	64902/10768/586/587/10390/55349/1119/56994/51380/1491/1759/55500/2729/2876/2877/2878/2879/2882/2936/4524/5833/10400/5337/6472/6647/6648/6649/7298	28
WP3646	Hepatitis C and hepatocellular carcinoma	37/3955	47/5488	0.197164252456399	0.750583912799531	0.712797079660882	207/598/330/332/836/842/595/960/1026/1284/2017/3577/1870/356/3091/6927/3569/5595/5599/4312/4609/26509/4790/4843/5420/5743/5781/5879/6241/4088/4089/6654/6774/7040/7046/7410/7422	37
WP272	Blood clotting cascade	12/3955	14/5488	0.204496530756979	0.757597885757397	0.71945794642865	2159/2160/2161/2152/2153/2157/3816/3818/5327/5328/5054/7450	12
WP2895	Differentiation of white and brown adipocyte	12/3955	14/5488	0.204496530756979	0.757597885757397	0.71945794642865	650/655/1051/1054/10205/51316/5468/10891/133522/4086/4090/23090	12
WP4928	MAPK pathway in congenital thyroid cancer	12/3955	14/5488	0.204496530756979	0.757597885757397	0.71945794642865	673/2002/2353/8844/5604/5605/5595/4609/5894/6464/6654/6655	12
WP5063	FOXP3 in COVID-19	12/3955	14/5488	0.204496530756979	0.757597885757397	0.71945794642865	941/942/50943/3559/3560/3561/3569/3572/3575/6774/6776/6777	12
WP4258	lncRNA in canonical Wnt signaling and colorectal cancer	51/3955	66/5488	0.210903509766098	0.758448125422329	0.720265382266056	324/467/8312/8313/595/894/1021/1454/1457/1459/283106/1460/1488/1499/56998/80319/1855/1856/10023/23401/7976/7855/8323/8324/8325/283120/83999/4041/4040/4609/51701/5328/64840/4919/4920/8607/6259/59343/5176/6422/6423/6425/6929/6932/83439/6934/7482/7473/54361/7474/81029	51
WP3879	4-hydroxytamoxifen, dexamethasone, and retinoic acids regulation of p27 expression	15/3955	18/5488	0.215322962655544	0.758448125422329	0.720265382266056	207/1977/1978/5604/5605/5606/5608/4296/4217/5595/8569/2872/55872/5894/7248	15
WP3893	Development and heterogeneity of the ILC family	15/3955	18/5488	0.215322962655544	0.758448125422329	0.720265382266056	196/64919/8320/2625/6927/3398/3600/3606/3553/90865/3569/4783/6095/30009/7124	15
WP4300	Extracellular vesicles in the crosstalk of cardiac cells	15/3955	18/5488	0.215322962655544	0.758448125422329	0.720265382266056	332/967/975/1956/2114/3315/3479/3569/3791/4318/5728/6647/6696/6774/7099	15
WP5103	Progeria-associated lipodystrophy	15/3955	18/5488	0.215322962655544	0.758448125422329	0.720265382266056	8815/2200/2339/4000/4001/84823/142/5424/5468/5965/4088/4089/83932/7040/7486	15
WP545	Complement activation	15/3955	18/5488	0.215322962655544	0.758448125422329	0.720265382266056	712/713/714/715/716/717/720/721/727/729/1604/629/1675/5199/5648	15
WP138	Androgen receptor signaling pathway	62/3955	81/5488	0.219855918948676	0.758448125422329	0.720265382266056	207/573/90427/811/857/595/898/998/1026/1385/1387/1499/1616/11034/1956/2033/2119/2274/2288/2316/2308/8850/11143/3985/4193/8648/10499/8202/8031/9611/8431/7182/11315/23598/10401/5295/5296/5052/29893/5728/5879/5883/5901/5925/5970/387/388/9604/9475/860/25942/23411/4088/4089/6714/6774/10273/7041/7050/7337/57178/24149	62
WP3931	Embryonic stem cell pluripotency pathways	62/3955	81/5488	0.219855918948676	0.758448125422329	0.720265382266056	10097/90/207/10000/324/369/8312/657/659/673/1499/1855/1856/1956/2002/2258/2247/2252/2254/2260/2263/2261/2353/7976/8322/7855/8323/8324/8325/2549/6927/3572/3976/4041/4040/5604/5605/5606/5607/5608/6300/5597/4193/5154/5155/5156/5159/5296/5728/5781/5894/4086/4089/4090/4092/6654/6774/7482/7473/54361/7474/81029	62
WP4540	Hippo signaling regulation pathways	62/3955	81/5488	0.219855918948676	0.758448125422329	0.720265382266056	998/999/1009/1012/1015/28513/64403/1001/1003/1004/1436/1499/1956/1969/2260/2263/2261/2321/2322/2324/2767/2771/2773/2774/2776/3643/3791/3815/26524/4485/4804/4915/5156/5159/23236/5330/5331/5332/5564/5565/5566/5567/5571/51422/5573/5575/5577/5580/5581/5590/23683/5879/387/4088/6788/6932/83439/6934/7003/8463/7004/7010	62
WP26	S1P receptor signal transduction	18/3955	22/5488	0.221214036581513	0.758448125422329	0.720265382266056	207/10000/427/2770/2771/2773/6300/5595/5597/5287/23236/5330/5331/29127/1901/1903/8877/56848	18
WP357	Fatty acid biosynthesis	18/3955	22/5488	0.221214036581513	0.758448125422329	0.720265382266056	31/32/47/2180/2181/2182/51703/23305/55902/1891/55268/79746/1892/2194/51102/5091/55825/6319	18
WP3668	Hypothesized pathways in pathogenesis of cardiovascular disease	18/3955	22/5488	0.221214036581513	0.758448125422329	0.720265382266056	285/2022/2200/2316/4052/4053/5595/5599/7182/10631/860/5054/6464/4088/4089/7046/7048/7049	18
WP4496	Signal transduction through IL1R	24/3955	30/5488	0.225538356212483	0.759510233119201	0.721274020010225	1147/51295/3552/3553/3554/3556/3557/3569/3654/3656/11213/5606/5608/4214/9020/5599/4790/4792/5970/7040/7043/7124/54472/7189	24
WP1471	Target of rapamycin (TOR) signaling	27/3955	34/5488	0.225651590999183	0.759510233119201	0.721274020010225	207/84335/998/54541/1978/2280/3156/3422/5564/5565/5571/51422/55615/79899/5879/6009/253260/6198/57521/10670/64121/58528/7248/7249/8408/9706/25989	27
WP43	Oxidation by cytochrome P450	27/3955	34/5488	0.225651590999183	0.759510233119201	0.721274020010225	1528/80777/51700/1727/51167/1545/57404/56603/1593/1594/1555/1558/1573/120227/29785/113612/1576/1577/1551/57834/66002/8529/4051/285440/1595/9420/5447	27
WP4659	Gastrin signaling pathway	81/3955	107/5488	0.232653099429612	0.778330369000885	0.739146689096951	207/302/64283/408/409/1386/572/9564/598/329/330/332/650/836/595/960/998/999/1026/1147/9076/1385/1499/1956/1958/1978/2002/2353/2308/2534/2776/51564/3067/3667/3688/3717/3815/9314/5604/4296/5595/5599/5601/4208/4209/4316/4609/4790/4792/5058/5290/5295/5296/8503/5335/5468/5566/5580/5581/5587/5743/5781/5879/5894/5970/387/388/29984/6194/6198/5054/6464/6548/6550/6654/6714/6774/7032/7082/7422/7525	81
WP2637	Interleukin-1 (IL-1) structural pathway	38/3955	49/5488	0.246051955977589	0.793199209630352	0.753266983973904	1386/1147/1977/2002/2353/3552/3554/3556/3654/3656/3665/5604/5605/5606/5608/5609/4214/9020/4215/1326/5602/5600/5595/5599/5601/9261/4155/8569/2872/4609/4790/4792/5970/6294/257397/10010/54472/7189	38
WP1434	Osteopontin signaling	11/3955	13/5488	0.250824900757031	0.793199209630352	0.753266983973904	1147/3685/3690/5604/9020/5595/4318/4790/5328/5970/6696	11
WP3644	NAD+ metabolism	11/3955	13/5488	0.250824900757031	0.793199209630352	0.753266983973904	952/10135/64802/349565/4907/142/23411/23410/23408/51548/51547	11
WP4584	Biomarkers for pyrimidine metabolism disorders	11/3955	13/5488	0.250824900757031	0.793199209630352	0.753266983973904	1152/1723/1806/51251/80324/6240/6241/50484/7084/1890/7298	11
WP5192	Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids	11/3955	13/5488	0.250824900757031	0.793199209630352	0.753266983973904	207/56624/64781/3091/4790/5290/5337/1901/1903/56848/7248	11
WP2828	Bladder cancer	29/3955	37/5488	0.254957296595435	0.793199209630352	0.753266983973904	369/673/595/999/1019/1026/1612/23604/1956/2064/2261/1839/5604/5605/4193/4312/4313/4318/4609/4893/5295/5296/5894/11186/5925/6714/7057/1890/7422	29
WP3937	Microglia pathogen phagocytosis pathway	29/3955	37/5488	0.254957296595435	0.793199209630352	0.753266983973904	10095/712/713/714/1535/1536/2207/2209/3055/3684/3689/4067/4688/4689/5286/5290/5291/5294/5295/5296/8503/5336/5879/27036/6850/54210/7305/7410/10451	29
WP536	Calcium regulation in cardiac cells	77/3955	102/5488	0.255451397292657	0.793199209630352	0.753266983973904	107/196883/111/112/113/115/153/154/309/408/409/483/488/489/490/773/775/776/782/811/8536/818/814/1131/2280/2697/2701/2702/2705/2707/10052/2767/2770/2771/2773/2775/2776/2782/2783/59345/2791/55970/2786/2787/2869/2870/3708/3710/3760/5569/5570/11142/5331/5350/5566/5567/5573/5575/5577/5580/5581/5590/5587/10636/6004/64407/5997/5998/5999/8490/8787/2810/6546/57620/7531/7532/7534	77
WP2324	AGE/RAGE pathway	49/3955	64/5488	0.256423660957673	0.793199209630352	0.753266983973904	207/249/1386/836/841/842/998/1147/1650/1956/7430/2308/4303/3091/3643/3667/3717/3958/5604/5595/5599/5601/4322/4323/4313/4316/4318/4478/4481/4790/4792/4843/4846/5321/5580/5590/5879/5894/5970/387/6464/4088/6647/6714/6772/6774/6776/6777/114609	49
WP167	Eicosanoid synthesis	14/3955	17/5488	0.257559666631984	0.793199209630352	0.753266983973904	246/241/1800/2678/5320/5321/8398/50640/5730/9536/80142/5742/5743/6916	14
WP325	Triacylglyceride synthesis	14/3955	17/5488	0.257559666631984	0.793199209630352	0.753266983973904	10554/10555/56894/56895/8540/8694/8443/57678/2819/3991/4023/80168/346606/57104	14
WP3877	MYD88 distinct input-output pathway	14/3955	17/5488	0.257559666631984	0.793199209630352	0.753266983973904	3552/3654/4790/92610/7096/81793/7097/7099/7100/10333/51311/54106/7189/7334	14
WP4784	Proteoglycan biosynthesis	14/3955	17/5488	0.257559666631984	0.793199209630352	0.753266983973904	126792/11285/113189/9469/22856/55790/2132/2137/9060/1836/347734/51000/64131/64132	14
WP1591	Heart development	23/3955	29/5488	0.259278478166756	0.793199209630352	0.753266983973904	8553/650/657/659/1499/2065/3170/2627/23462/4208/406937/4772/4773/4775/4776/5781/6469/4086/4089/6722/6909/7422/7424	23
WP262	Ebstein-Barr virus LMP1 signaling	17/3955	21/5488	0.26008887127372	0.793199209630352	0.753266983973904	6364/1147/3320/8517/3654/9020/4215/5599/4790/4791/4792/9260/5970/7124/8717/7185/7189	17
WP3658	Wnt/beta-catenin signaling pathway in leukemia	17/3955	21/5488	0.26008887127372	0.793199209630352	0.753266983973904	207/324/8313/595/1499/2322/8323/3728/4041/4040/4609/5371/5467/26108/5914/862/6929	17
WP395	IL-4 signaling pathway	40/3955	52/5488	0.269423321399319	0.817152051716616	0.776013962156511	207/1386/572/332/1051/1147/9046/2002/2033/2242/2316/2353/2625/3269/3561/3566/3667/8660/3717/5600/5595/4783/4790/4792/5290/5295/5296/5781/5970/6198/6464/8651/9021/9655/6654/6772/6774/6776/6777/6778	40
WP3942	PPAR signaling pathway	37/3955	48/5488	0.273905868415542	0.821452661220773	0.780098065003709	30/34/51/8309/2180/2181/2182/51703/23305/364/948/1374/1376/1593/1622/2168/2171/9415/3158/3611/4023/4199/4312/5105/5106/5170/5360/5465/5467/5468/6256/6257/6319/6342/376497/11001/10999	37
WP560	TGF-beta receptor signaling	37/3955	48/5488	0.273905868415542	0.821452661220773	0.780098065003709	25805/1387/1499/2022/2033/2280/2353/3624/3694/10637/3976/4052/5595/5601/4790/860/5054/6497/4086/4088/4089/4090/4092/6696/6772/6774/7030/7040/7046/7048/7049/7050/7057/7124/9839/9372/23090	37
WP5094	Orexin receptor pathway	76/3955	101/5488	0.275305692619281	0.821452661220773	0.780098065003709	8553/655/657/689/1026/1364/1346/2920/51523/1628/9201/1734/1846/1958/1959/2324/2353/2354/2355/4616/84662/1839/3091/3284/3309/3383/3397/3399/3553/3569/3663/3726/3777/9314/3908/3949/3991/4023/84230/7798/23764/7873/5595/4322/4314/4609/4846/8013/23596/26031/5069/50940/5163/8864/5295/5296/5337/5468/5914/6241/861/862/860/6401/27230/6446/6506/6696/6722/3371/7124/29896/7412/7422/7428/51067	76
WP3676	BDNF-TrkB signaling	22/3955	28/5488	0.296420507960742	0.842462522792909	0.800050221874273	107/207/673/1385/1742/29904/1978/2549/5604/8569/4893/4915/5294/5335/6009/6195/6198/6464/6654/7225/7248/7249	22
WP4149	White fat cell differentiation	22/3955	28/5488	0.296420507960742	0.842462522792909	0.800050221874273	1051/1052/1385/1879/1959/2308/2624/2625/3662/9314/688/2122/7026/2908/5468/5914/6095/6776/6777/83439/7090/23090	22
WP716	Vitamin A and carotenoid metabolism	22/3955	28/5488	0.296420507960742	0.842462522792909	0.800050221874273	64240/8854/220/948/56603/8694/9249/4023/9227/29881/5914/5916/5947/5948/5950/5959/54884/6256/6257/949/195814/6820	22
WP4521	Glycosylation and related congenital defects	19/3955	24/5488	0.30042045065121	0.842462522792909	0.800050221874273	56052/79868/199857/85365/10195/79053/2683/22845/1798/8813/8818/54344/84061/4247/9526/4351/5373/79644/7991	19
WP4925	Unfolded protein response	19/3955	24/5488	0.30042045065121	0.842462522792909	0.800050221874273	468/22926/27113/596/10018/637/835/841/9451/1965/2081/3309/3553/51360/5366/23645/8795/10628/7494	19
WP1772	Apoptosis modulation and signaling	61/3955	81/5488	0.302543850095078	0.842462522792909	0.800050221874273	84883/572/9531/578/27113/596/597/598/10018/599/637/638/329/330/332/640/90427/664/666/826/834/843/835/836/837/839/841/842/8837/8738/1616/56616/355/356/2353/3554/7850/3654/8567/9020/4217/5595/5599/4170/4671/4790/4792/8682/5366/5587/5783/51651/8795/8794/8793/7132/7133/54472/8717/7187/7189	61
WP3872	Regulation of apoptosis by parathyroid hormone-related protein	16/3955	20/5488	0.303766723538123	0.842462522792909	0.800050221874273	207/578/596/597/598/83596/23786/599/637/666/2931/3655/3691/4170/4609/5294	16
WP2023	Cell differentiation - expanded index	10/3955	12/5488	0.305229231131471	0.842462522792909	0.800050221874273	10014/3398/9314/10637/4208/4209/406937/860/6722/6774	10
WP247	Small ligand GPCRs	10/3955	12/5488	0.305229231131471	0.842462522792909	0.800050221874273	1268/1269/5724/5729/5732/5734/5737/1901/1903/8698	10
WP3849	MAPK and NFkB signaling pathways inhibited by Yersinia YopJ	10/3955	12/5488	0.305229231131471	0.842462522792909	0.800050221874273	1147/8517/5608/4214/9020/4790/4792/5894/6237/7189	10
WP4891	COVID-19 adverse outcome pathway	10/3955	12/5488	0.305229231131471	0.842462522792909	0.800050221874273	59272/6347/6348/1440/3627/3553/3559/3569/7113/7124	10
WP3413	NOTCH1 regulation of endothelial cell calcification	13/3955	16/5488	0.305834327215914	0.842462522792909	0.800050221874273	249/813/28514/54567/2261/2702/3672/3714/4256/5327/6303/55553/7422	13
WP4493	Cells and molecules involved in local acute inflammatory response 	13/3955	16/5488	0.305834327215914	0.842462522792909	0.800050221874273	727/729/3383/3552/3569/3676/3688/3689/3827/6403/6404/7124/7412	13
WP5033	Genes associated with the development of rheumatoid arthritis	13/3955	16/5488	0.305834327215914	0.842462522792909	0.800050221874273	640/958/4261/1493/115352/3123/3559/3572/3663/3685/6583/6775/7185	13
WP5218	Extrafollicular B cell activation by SARS-CoV-2	47/3955	62/5488	0.307838300937787	0.842462522792909	0.800050221874273	57379/60468/613/29760/720/6363/930/912/933/958/959/973/941/1378/1380/6387/643/10148/2308/29851/23308/3433/8519/3455/3569/3662/9636/3687/3689/4094/4240/931/5079/5133/639/6402/57823/6776/6850/30009/7099/9168/7124/8741/10673/7494/9839	47
WP289	Myometrial relaxation and contraction pathways	88/3955	118/5488	0.30873742712773	0.842462522792909	0.800050221874273	59/60/107/196883/111/112/113/115/133/408/409/466/1386/467/468/22809/488/489/800/818/1264/1265/1385/10488/8525/2114/2353/2551/2553/2697/2776/2782/2783/59345/2791/55970/2786/2787/2869/2870/9446/2980/2981/3485/3487/3488/3489/3553/3569/3708/3710/23764/4790/4846/5142/5144/5569/5570/11142/5331/5333/5335/5336/5566/5567/5573/5575/5577/5580/5581/5590/5587/10267/10266/10268/10636/6004/64407/5997/5998/5999/8490/8787/2810/6546/7531/7532/7534	88
WP1971	Integrated cancer pathway	33/3955	43/5488	0.309818645157537	0.842462522792909	0.800050221874273	207/466/472/545/572/580/27113/596/836/841/842/993/994/1017/1019/1026/1030/1111/11200/4217/4193/4312/4436/2956/4609/10811/5347/5451/5728/10111/5925/4088/6772	33
WP2849	Hematopoietic stem cell differentiation	33/3955	43/5488	0.309818645157537	0.842462522792909	0.800050221874273	28/91/863/947/4261/1435/1440/2353/2354/2624/55502/79366/3552/3553/3569/3663/3690/3757/4254/4005/4066/4582/4601/4773/5292/8780/861/23541/6688/6776/7068/80342/23650	33
WP4787	Osteoblast differentiation and related diseases	66/3955	88/5488	0.313754623805914	0.847607515790353	0.804936199205941	650/657/659/1499/28514/54567/2247/2252/2254/2260/2263/2261/7976/8322/7855/8323/8324/8325/2736/2737/54626/55502/23462/3549/3714/4041/4040/5602/5600/6300/5603/5595/5597/5599/5601/4853/4854/4855/5286/5287/5290/5291/5294/5295/5296/8503/23533/5468/5580/5581/5590/5587/3516/860/4086/4089/4090/6608/6662/6772/7482/7473/54361/7474/81029/7483	66
WP5115	Network map of SARS-CoV-2 signaling pathway	133/3955	180/5488	0.322610947648191	0.847607515790353	0.804936199205941	59272/60/196/207/84335/341/347/8542/55937/637/332/684/11119/708/715/716/814/84433/836/838/841/842/6356/6347/6364/6367/6348/6351/6355/891/1234/929/9332/10666/920/926/1051/629/3075/3426/5199/1294/1508/1509/1514/2919/3627/6387/58191/2920/2921/6374/6372/4283/3577/3579/54541/64798/1843/1958/1974/1977/1978/84985/2247/2335/2353/2534/11345/51512/3043/3091/3122/3123/3429/10964/2537/64135/8519/10410/8517/3603/3606/8807/3552/3553/7850/90865/3569/3654/10379/83737/3675/3699/3717/3726/3932/116844/81631/5599/57506/64386/4599/4775/4791/55922/114548/4939/10038/5743/5879/6009/6194/57521/6237/6241/6288/6289/6403/5104/5054/4086/4090/6772/55240/29110/7048/7124/7187/7189/7226/8408/27072	133
WP2369	Histone modifications	27/3955	35/5488	0.322799562545868	0.847607515790353	0.804936199205941	55870/84444/8726/79813/10919/2145/4297/9757/58508/8085/55904/64324/7799/26040/9739/23067/29072/79918/80854/133383/83852/6419/64754/114826/10322/6839/79723	27
WP3614	Photodynamic therapy-induced HIF-1 survival signaling	27/3955	35/5488	0.322799562545868	0.847607515790353	0.804936199205941	284/285/578/597/598/637/332/664/665/1906/54583/3091/55662/3098/3485/4170/4843/5211/5230/5315/5366/5743/5054/6515/7039/7043/7422	27
WP4565	Neural crest cell migration in cancer	27/3955	35/5488	0.322799562545868	0.847607515790353	0.804936199205941	207/10000/375/1009/2048/2049/2050/2151/2353/57498/4313/4318/25791/4804/4915/5058/5062/10298/5290/5291/5294/8503/23533/5879/387/6272/6774	27
WP4666	Hepatitis B infection	98/3955	132/5488	0.324637081248174	0.847607515790353	0.804936199205941	207/10000/369/1386/468/537/572/596/637/332/673/843/836/841/842/1026/1147/1385/10488/90993/84699/148327/9586/1387/1643/1654/1959/2002/2033/355/356/2353/3339/64135/3454/9641/8517/3569/3654/3665/3717/5604/5605/5606/5608/5609/4214/5602/5600/6300/5603/5595/5599/5601/57506/4318/4609/4772/4773/4775/4776/4790/4893/5290/5291/5295/5296/8503/2185/5894/5970/4088/4089/6654/6655/6714/6772/6773/6774/6775/6776/6777/6778/29110/7040/7043/7046/7048/148022/114609/7097/7098/7099/7124/7187/7189/7419/7534	98
WP5144	NRP1-triggered signaling pathways in pancreatic cancer 	38/3955	50/5488	0.327982608328866	0.847607515790353	0.804936199205941	207/10000/9564/898/9134/1003/1017/1277/1278/1956/2321/2931/3082/3791/5604/5605/5595/4313/4318/4790/4791/8829/5361/5362/91584/5879/5966/5970/4088/4089/6591/6714/7040/7043/7046/7048/7049/7422	38
WP1982	Sterol regulatory element-binding proteins (SREBP) signaling	49/3955	65/5488	0.328417778165908	0.847607515790353	0.804936199205941	31/47/84532/207/267/22926/1385/1595/1622/2194/2222/57678/2931/3156/3157/3422/3638/51141/3837/3949/23175/4023/4047/51360/7376/5290/5468/133522/5564/5565/5566/5571/51422/5950/56681/51128/22937/949/6319/6396/10484/10483/10427/9632/9871/23411/6713/6721/7528	49
WP2447	Amyotrophic lateral sclerosis (ALS)	24/3955	31/5488	0.32971007755798	0.847607515790353	0.804936199205941	57679/572/596/598/637/834/836/842/847/1616/79139/2876/5605/5608/4217/5530/5532/5868/5879/6506/6647/7124/7132/10452	24
WP4148	Splicing factor NOVA regulated synaptic proteins	24/3955	31/5488	0.32971007755798	0.847607515790353	0.804936199205941	375790/288/334/490/23705/818/858/10752/22883/1600/1946/2035/2036/2037/3778/4134/5601/23154/4756/5332/5590/2054/6813/54386	24
WP4685	Melanoma	46/3955	61/5488	0.335646921854322	0.847607515790353	0.804936199205941	207/10000/369/572/578/673/595/999/1019/1021/1026/1385/1643/1870/1871/2002/2353/1647/4616/10912/3791/3815/5604/5605/5595/4193/4286/4763/4893/5058/5290/5291/5295/5296/8503/51426/80243/5728/5879/5894/5925/25759/6654/6655/8859/7414	46
WP117	GPCRs, other	21/3955	27/5488	0.336923636536289	0.847607515790353	0.804936199205941	154/1234/1951/1131/1268/3577/3579/2833/1909/2149/29933/11245/2841/2918/59352/5032/53829/5737/1901/6608/6752	21
WP2839	Hair follicle development: organogenesis - part 2 of 3	21/3955	27/5488	0.336923636536289	0.847607515790353	0.804936199205941	595/894/999/1499/10913/2263/2736/23560/3624/3688/3911/4041/4609/4684/4790/5154/5156/860/6469/6608/7474	21
WP2870	Extracellular vesicle-mediated signaling in recipient cells	21/3955	27/5488	0.336923636536289	0.847607515790353	0.804936199205941	207/324/8312/1499/1956/2064/3082/4240/4893/23533/8842/5894/4088/4089/7039/7040/7043/7046/7048/7049/7474	21
WP2876	Pregnane X receptor pathway	21/3955	27/5488	0.336923636536289	0.847607515790353	0.804936199205941	5243/1244/10257/1555/1576/1577/1551/66002/2308/2939/3320/8648/10499/8202/8856/8204/10891/6256/6714/27286/54658	21
WP4746	Thyroid hormones production and peripheral downstream signaling effects	54/3955	72/5488	0.340856412492852	0.847607515790353	0.804936199205941	84335/10000/364/1386/572/842/10488/1499/1734/50506/405753/2260/2308/10818/3685/3690/389434/51780/152831/5604/7867/4193/11343/57224/4881/7849/5290/23236/57104/5468/10891/5566/5593/5894/6009/6194/27330/6198/57521/6256/9728/6469/51548/6567/5172/6654/6714/9882/7067/7068/7248/7249/7270/54361	54
WP4197	Immune response to tuberculosis	18/3955	23/5488	0.34444712031346	0.847607515790353	0.804936199205941	3430/3437/8519/3454/3455/3459/3659/10379/3717/9282/4599/4938/5696/5771/8651/6772/6773/6890	18
WP4357	NRF2-ARE regulation	18/3955	23/5488	0.34444712031346	0.847607515790353	0.804936199205941	7965/1051/8452/2048/2534/2729/2939/3162/3643/4094/5599/1728/192111/5290/9978/23657/6714/7525	18
WP5036	Angiotensin II receptor type 1 pathway	18/3955	23/5488	0.34444712031346	0.847607515790353	0.804936199205941	59272/59/1277/1278/2161/3091/3589/3572/5608/80310/5781/5894/6237/4088/4089/7040/7046/7048	18
WP195	IL-1 signaling pathway	40/3955	53/5488	0.351278444386439	0.847607515790353	0.804936199205941	207/1386/6347/1147/51295/8517/3552/3553/3554/3556/3654/3656/11213/5604/5605/5606/5608/5609/4214/9020/10746/4215/5595/5599/5601/9261/4790/4792/57162/5295/5296/5335/5590/5781/5966/5970/257397/54472/7189/7334	40
WP35	G protein signaling pathways	59/3955	79/5488	0.351915294303032	0.847607515790353	0.804936199205941	107/196883/111/112/113/115/8165/11216/9590/11214/9495/9472/9465/10142/2767/2768/10672/9630/2769/2770/2771/2773/2774/2775/2776/2782/2783/2791/55970/2786/2787/3708/3760/4893/5136/5153/5137/5141/5142/5144/5150/27115/5151/8622/5331/5530/5566/5567/5573/5575/5577/5580/5581/5590/5587/23683/387/6237/6548	59
WP3645	NAD+ biosynthetic pathways	15/3955	19/5488	0.352260225300915	0.847607515790353	0.804936199205941	952/3620/10135/64802/142/10038/143/23475/23411/23410/23408/51548/51547/6999/8658	15
WP727	Monoamine transport	15/3955	19/5488	0.352260225300915	0.847607515790353	0.804936199205941	43/114907/3553/3554/3690/5934/10066/6532/6804/6999/7041/7124/4982/7249/10497	15
WP3303	RAC1/PAK1/p38/MMP2 pathway	48/3955	64/5488	0.356371470463039	0.847607515790353	0.804936199205941	207/284/285/572/332/842/1147/1499/9046/1956/1978/2064/2335/2308/2886/8517/3688/5600/6300/5603/5595/5599/5601/4313/4436/4609/4690/4790/4792/4843/4893/5058/5290/5295/5781/5879/5970/6654/6714/6774/6776/6777/3925/7010/7075/79155/79931/10413	48
WP2291	Deregulation of Rab and Rab effector genes in bladder cancer	12/3955	15/5488	0.360267282061502	0.847607515790353	0.804936199205941	23086/9648/8567/25924/5873/5874/9501/54843/94120/94121/94122/201294	12
WP4872	MAP3K1 role in promoting and blocking gonadal determination	12/3955	15/5488	0.360267282061502	0.847607515790353	0.804936199205941	8312/1499/2254/2263/10023/10912/4214/4216/5600/387/6662/54361	12
WP1433	Nucleotide-binding oligomerization domain (NOD) pathway	26/3955	34/5488	0.360506525286691	0.847607515790353	0.804936199205941	9447/84674/834/838/841/842/1147/10980/50506/3320/8517/3606/3553/4210/4671/4792/58484/55655/114548/10392/64127/639/5879/5970/8767/10910	26
WP4313	Ferroptosis	45/3955	60/5488	0.364753457189718	0.847607515790353	0.804936199205941	2180/2181/2182/51703/23305/84883/1645/246/10533/875/51510/55847/27235/1356/1491/1536/1803/2222/2643/2729/2879/3156/3162/3315/3658/10162/84557/81631/8031/27035/5093/5094/5447/5621/6303/112483/4891/6510/23516/64116/30061/23657/55240/7037/7419	45
WP186	Homologous recombination	9/3955	11/5488	0.368144865767903	0.847607515790353	0.804936199205941	472/675/4683/5424/5425/10714/10111/5893/6117	9
WP229	Irinotecan pathway	9/3955	11/5488	0.368144865767903	0.847607515790353	0.804936199205941	4363/1244/9429/1066/8824/1576/1577/54658/54575	9
WP3876	BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation	9/3955	11/5488	0.368144865767903	0.847607515790353	0.804936199205941	10018/650/1499/1634/2308/6422/4086/4090/54361	9
WP4495	IL-10 anti-inflammatory signaling pathway 	9/3955	11/5488	0.368144865767903	0.847607515790353	0.804936199205941	644/645/3162/3587/3552/3569/6772/6773/6774	9
WP4707	Aspirin and miRNAs	9/3955	11/5488	0.368144865767903	0.847607515790353	0.804936199205941	10257/283120/4790/4846/5163/5465/5742/5743/7422	9
WP5191	Resolvin E1 and resolvin D1 signaling pathways promoting inflammation resolution	9/3955	11/5488	0.368144865767903	0.847607515790353	0.804936199205941	207/1240/2048/2358/1241/5163/5290/5291/5294	9
WP3844	PI3K-AKT-mTOR signaling pathway and therapeutic opportunities	23/3955	30/5488	0.370138878873654	0.847607515790353	0.804936199205941	207/572/1978/2308/4303/2887/4846/4893/5163/5290/5291/5294/5295/5296/8503/5728/9821/6009/253260/57521/7942/7249/8408	23
WP3858	Toll-like receptor signaling related to MyD88	23/3955	30/5488	0.370138878873654	0.847607515790353	0.804936199205941	1147/9641/8517/3654/3665/4790/4791/5966/5970/29110/148022/114609/7096/7097/7098/7099/7100/10333/51311/54106/54472/7187/7189	23
WP4868	Type I interferon induction and signaling during SARS-CoV-2 infection	23/3955	30/5488	0.370138878873654	0.847607515790353	0.804936199205941	59272/5610/64135/3454/3455/9641/3665/10379/57506/4938/4939/4940/6772/6773/29110/7097/7098/7099/10333/54106/7113/7187/7189	23
WP2059	Alzheimer's disease and miRNA effects	154/3955	210/5488	0.370978440943988	0.847607515790353	0.804936199205941	102/6868/207/10000/324/83464/348/351/369/468/22926/23130/55102/488/489/8312/8313/23621/572/637/673/775/776/836/841/842/1020/8851/54480/1139/1147/1435/1454/1457/1459/283106/1460/1499/1536/1855/1856/5610/9451/1965/2081/355/10023/23401/7976/7855/8323/8324/8325/2597/2776/3028/3416/3552/3553/3569/3643/3667/8660/3708/3710/3799/3800/64837/89953/4023/4035/4041/4040/5604/5605/5609/4217/5602/5595/5599/5601/90550/4311/4790/4843/27035/4893/29982/5290/5291/5295/5296/8503/23236/5330/5331/5332/5481/10105/5530/5532/5663/5664/55851/5682/5683/5684/5685/5686/5687/5689/5690/5691/5692/5693/5694/5701/5704/5707/5718/5719/10213/9861/5713/5743/5894/9821/5970/57142/291/292/293/7124/7132/7846/10376/7277/79861/7280/347733/10383/84617/8408/9706/7419/81671/55062/26100/7482/7473/54361/7474/81029/7494	154
WP51	Regulation of actin cytoskeleton	85/3955	115/5488	0.371596048589249	0.847607515790353	0.804936199205941	10152/60/87/324/2909/8874/9564/624/673/929/998/1073/1131/1445/26999/81624/1793/1956/55740/7430/2149/2245/2258/2247/2252/2254/2260/2263/2261/2335/28964/2768/10672/55970/8826/3672/3984/5604/5605/5595/5597/22808/4478/4628/4638/10787/4893/5058/5062/10298/5154/5155/5156/5159/5216/5286/5287/5290/5291/5294/5295/5296/8503/23533/8394/8395/23396/5879/5894/8045/5962/387/9475/6237/22800/6548/6654/6655/54434/85464/7414/7429/7454/8936/10163	85
WP304	Kit receptor signaling pathway	42/3955	56/5488	0.37362350641164	0.848725002219035	0.805997427736612	207/572/596/695/1399/1796/2033/2353/2534/2887/2886/3717/3726/3815/4254/4067/5604/5605/5595/5599/4145/4286/5295/5296/5335/5781/5894/6194/6195/6198/6464/6591/8651/9306/6654/6714/6772/6774/6776/6777/6909/7006	42
WP3680	Physico-chemical features and toxicity-associated pathways	39/3955	52/5488	0.383050606526486	0.866573503289428	0.822947377265704	10097/207/324/8312/8536/1026/1499/23002/1855/1956/2002/2064/2335/7976/8322/7855/8323/8324/8325/2876/5604/5599/4609/4638/4690/5058/5216/5217/5294/5335/5894/387/9475/6464/6647/6654/6714/6776/7039	39
WP710	DNA damage response (only ATM dependent)	71/3955	96/5488	0.387103257481668	0.870716918534389	0.826882199523505	207/10000/324/472/8312/572/578/27113/596/10018/638/847/595/894/901/998/1026/1499/1855/1856/2064/356/10023/3643/3667/3949/4214/4216/5602/5599/5601/4193/197259/4609/4790/4791/4893/5106/5163/5286/5287/5290/5291/5294/5295/5296/8503/23533/5328/5366/5529/5728/5879/5934/387/6342/6464/4088/4089/6648/6654/6655/6932/83439/6934/7040/7482/7473/54361/7474/81029	71
WP127	IL-5 signaling pathway	28/3955	37/5488	0.389076720451087	0.870716918534389	0.826882199523505	207/596/695/1439/2002/2353/2931/3717/4067/5604/5605/5595/4609/5294/5295/5296/5781/5894/6194/6195/6198/6464/6654/6772/6774/6776/6777/6850	28
WP3845	Canonical and non-canonical Notch signaling	17/3955	22/5488	0.392263309227228	0.870716918534389	0.826882199523505	102/1147/28514/54567/23462/3714/9794/84441/55534/4237/4853/4854/4855/5663/5664/3516/6237	17
WP5092	Interactions of natural killer cells in pancreatic cancer	17/3955	22/5488	0.392263309227228	0.870716918534389	0.826882199523505	102/6868/6347/6348/6351/10666/10225/2214/2308/2624/3002/100507436/4277/4609/259197/5551/7124	17
WP4630	Measles virus infection	84/3955	114/5488	0.393733773351511	0.870716918534389	0.826882199523505	103/572/578/27113/596/598/637/836/841/842/868/595/894/898/9134/30835/4179/1017/1019/1021/1147/1457/1459/283106/1460/5610/9451/440275/1965/8667/355/356/2353/3304/3305/3310/64135/3454/3455/9641/8517/3552/3553/3559/3560/3561/3569/3654/3665/10379/5602/5599/5601/57506/4478/4599/4790/4791/4792/4938/4939/4940/5290/5291/5295/5296/8503/9367/25898/5970/6504/6772/6773/6774/6776/6777/29110/7097/7099/54106/7128/8717/7187/7189	84
WP4018	Clear cell renal cell carcinoma pathways	60/3955	81/5488	0.395844384715714	0.870716918534389	0.826882199523505	31/32/47/207/84335/230/79365/8536/1012/80184/1387/64798/1956/2023/5169/2033/2194/2321/2597/2821/2887/3091/3098/3099/3101/3759/3791/8844/197257/4199/5155/5156/5159/5211/5213/5214/79605/5230/5236/55276/5313/5315/5352/29968/5728/9771/6009/57521/10993/29072/6472/8082/6774/7040/7043/7248/7249/7422/7428/6935	60
WP244	Alpha 6 beta 4 signaling pathway	25/3955	33/5488	0.400522976001402	0.870716918534389	0.826882199523505	207/1978/2549/3667/8660/3655/3691/284217/3908/3911/3912/3913/3914/3915/3918/5595/5295/5296/5580/5781/5879/387/6464/6654/6714	25
WP4874	CAMKK2 pathway	25/3955	33/5488	0.400522976001402	0.870716918534389	0.826882199523505	8874/8536/814/10645/1131/1385/10059/2033/28964/9759/3162/3383/4094/84557/5595/4773/5879/5894/5970/57521/23411/6786/7248/7412/7466	25
WP4971	Phosphoinositides metabolism	33/3955	44/5488	0.403942870343051	0.870716918534389	0.826882199523505	4534/10903/54545/8898/8897/9110/9107/55613/4952/5286/5287/5290/5291/5294/200576/8394/8395/23396/23236/5330/5331/5332/5333/113026/51196/5335/5336/23007/9651/5728/22908/6305/81846	33
WP5124	Alzheimer's disease	152/3955	208/5488	0.404300398590724	0.870716918534389	0.826882199523505	102/6868/207/10000/324/83464/348/351/369/468/22926/23130/55102/488/489/8312/8313/23621/572/637/673/775/776/836/841/842/1020/8851/1139/1147/1435/1454/1457/1459/283106/1460/1499/1536/1855/1856/5610/9451/1965/2081/355/10023/23401/7976/7855/8323/8324/8325/2597/2776/3028/3416/3552/3553/3569/3643/3667/8660/3708/3710/3799/3800/64837/89953/4023/4035/4041/4040/5604/5605/5609/4217/5602/5595/5599/5601/90550/4311/4790/4843/27035/4893/29982/5290/5291/5295/5296/8503/23236/5330/5331/5332/5481/10105/5530/5532/5663/5664/55851/5682/5683/5684/5685/5686/5687/5689/5690/5691/5692/5693/5694/5701/5704/5707/5718/5719/10213/9861/5713/5743/5894/9821/5970/57142/291/292/293/7124/7132/7846/10376/7277/79861/7280/347733/10383/84617/8408/9706/7419/55062/26100/7482/7473/54361/7474/81029/7494	152
WP4961	STING pathway in Kawasaki-like disease and COVID-19	14/3955	18/5488	0.405388130549525	0.870716918534389	0.826882199523505	1147/2152/2212/79792/9641/8517/3553/3708/4790/4792/114548/5966/5970/29110	14
WP5066	FOXA2 pathway	14/3955	18/5488	0.405388130549525	0.870716918534389	0.826882199523505	1244/10257/31/338/2194/3169/3170/2308/2938/2939/3667/8660/51085/133522	14
WP5193	Cholesterol synthesis disorders	14/3955	18/5488	0.405388130549525	0.870716918534389	0.826882199523505	1595/1717/10682/2222/3156/3157/3284/3422/4047/6307/4598/10654/6309/6713	14
WP4223	Ras signaling	107/3955	146/5488	0.410051182843464	0.877318809804621	0.833151730134823	27/207/10000/382/572/598/8315/998/1147/1436/1956/2002/1969/2114/55770/356/2260/2263/2261/2321/2322/2324/4303/2549/2782/2783/59345/2791/55970/2786/2787/8517/3643/3791/3815/8844/283455/5604/5605/5602/5595/5599/5601/22808/4763/4790/4804/4893/4915/5058/5062/10298/5156/5159/5290/5291/5295/5296/8503/51365/8399/81579/84647/5320/5321/8605/255189/8398/51196/5335/5336/5337/5338/5566/5567/5781/5868/5878/5879/5894/5898/5899/10928/5900/5908/9771/22821/9462/5924/25780/115727/11186/83593/5966/5970/23179/5863/387/9610/6237/22800/6464/25759/8036/6654/6655/7010	107
WP722	Serotonin HTR1 group and FOS pathway	22/3955	29/5488	0.413152601598984	0.880541452056522	0.83621213410402	673/1385/2002/2353/2770/2771/2773/2775/3352/3708/5604/5605/5606/5608/4214/5595/9261/7867/5170/5290/387/6722	22
WP49	IL-2 signaling pathway	30/3955	40/5488	0.415658459974773	0.880689890765773	0.836353099926306	207/596/894/1154/1399/2353/2534/3559/3560/3561/3932/5604/5605/5595/4609/9111/5295/2185/5781/5894/6194/6198/6464/9021/6654/6772/6774/6776/6777/6850	30
WP4830	GDNF/RET signaling axis	11/3955	14/5488	0.420695590757223	0.880689890765773	0.836353099926306	1499/79633/2625/2674/2737/26585/11020/5979/6092/6299/10252	11
WP53	ID signaling pathway	11/3955	14/5488	0.420695590757223	0.880689890765773	0.836353099926306	898/1017/2002/2004/3397/3398/3399/5079/7849/5925/5934	11
WP4806	EGFR tyrosine kinase inhibitor resistance	59/3955	80/5488	0.422665893641564	0.880689890765773	0.836353099926306	207/10000/369/558/572/596/598/10018/673/595/1956/1977/1978/2064/2065/2247/2263/2261/2549/3082/3479/3569/3717/3791/5604/5605/5595/22808/4609/4763/4893/3084/5154/5155/80310/5156/5159/5170/5290/5291/5295/5296/8503/5335/5336/5728/5894/6194/6198/6237/22800/6464/25759/6654/6655/6714/6774/7039/7422	59
WP4674	Head and neck squamous cell carcinoma	51/3955	69/5488	0.424631079814094	0.880689890765773	0.836353099926306	84962/207/10000/329/841/595/1019/1021/1026/1499/8452/54541/1956/1977/1978/2064/2195/2260/2263/2261/2280/2549/3664/9794/4790/4791/4853/4893/5170/5290/5291/5294/5295/5296/23533/5728/5925/5966/5970/6009/253260/6194/57521/27244/83667/4089/7048/7187/7248/7249/7422	51
WP5039	SARS-CoV-2 innate immunity evasion and cell-specific immune response	43/3955	58/5488	0.426407095087864	0.880689890765773	0.836353099926306	59272/682/841/6347/6348/6351/11126/2919/3627/6373/6387/2920/2921/6374/6372/4283/3579/79132/2033/84868/3066/3433/8519/3454/3455/3569/3665/3902/57506/4599/4790/4928/4088/6772/6773/10010/29110/7040/7124/8717/7187/7188/7189	43
WP205	IL-7 signaling pathway	19/3955	25/5488	0.427311371925207	0.880689890765773	0.836353099926306	207/572/598/595/2534/3559/3561/3575/5604/5605/5595/4609/5295/5296/2185/6772/6774/6776/6777	19
WP4829	mBDNF and proBDNF regulation of GABA neurotransmission	19/3955	25/5488	0.427311371925207	0.880689890765773	0.836353099926306	1385/1390/2555/2564/2568/3717/4804/4915/5290/5291/5294/5295/5296/8503/5335/5728/387/6464/6774	19
WP4758	Nephrotic syndrome	27/3955	36/5488	0.428455429475475	0.880689890765773	0.836353099926306	81/56052/54443/8542/977/23607/1285/27235/1493/8029/1871/2013/64423/3675/3691/3913/4000/4643/51196/5373/5420/5800/950/11346/7225/79809/84942	27
WP2857	Mesodermal commitment pathway	82/3955	112/5488	0.439451540576894	0.880689890765773	0.836353099926306	31/90/92/93/8728/84159/10124/10973/57198/8312/8313/63035/8553/655/657/659/708/203228/55704/595/11190/8646/23373/1488/8450/23181/28514/8320/57669/2132/2260/3169/3170/8322/7855/8325/2625/2627/79977/3172/3064/3624/3717/7403/9314/688/10637/54799/4211/22823/54892/51701/79668/5087/5090/84295/23007/5460/5566/5573/5916/27244/29072/154091/4086/4088/4089/6722/6926/83439/7003/8463/27324/55809/85363/57045/51366/10451/115825/7473/10413/23528	82
WP1991	SRF and miRs in smooth muscle differentiation and proliferation	8/3955	10/5488	0.439575420116053	0.880689890765773	0.836353099926306	894/2002/9314/4208/4209/406937/93649/6722	8
WP2436	Dopamine metabolism	8/3955	10/5488	0.439575420116053	0.880689890765773	0.836353099926306	1312/1644/4128/4129/1728/5566/5567/6647	8
WP2881	Estrogen receptor pathway	8/3955	10/5488	0.439575420116053	0.880689890765773	0.836353099926306	51/1545/57678/8431/5105/5166/5465/6774	8
WP3630	NAD metabolism, sirtuins and aging	8/3955	10/5488	0.439575420116053	0.880689890765773	0.836353099926306	2308/3091/10135/4790/142/5468/23411/23410	8
WP4259	Disorders of folate metabolism and transport	8/3955	10/5488	0.439575420116053	0.880689890765773	0.836353099926306	10840/1719/2618/4522/4524/6472/113235/7298	8
WP3527	Pre-implantation embryo	24/3955	32/5488	0.442591410020187	0.880689890765773	0.836353099926306	360/366/476/999/1045/1958/2101/2354/2624/2625/3662/9314/57504/4084/4603/4306/5087/5460/6597/30812/6926/83439/7004/7538	24
WP4564	Neural crest cell migration during development	24/3955	32/5488	0.442591410020187	0.880689890765773	0.836353099926306	207/10000/375/1009/2048/2049/2050/2151/2353/4313/4318/25791/4804/5058/5062/10298/5290/5291/5294/8503/23533/5879/387/6774	24
WP4686	Leucine, isoleucine and valine metabolism	16/3955	21/5488	0.443535850784212	0.880689890765773	0.836353099926306	27034/38/197322/549/586/587/594/1629/1892/26275/3028/3712/56922/64087/23417/5096	16
WP4864	Host-pathogen interaction of human coronaviruses - apoptosis	16/3955	21/5488	0.443535850784212	0.880689890765773	0.836353099926306	207/572/27113/596/598/10018/637/836/841/842/356/5600/6300/5603/4170/7124	16
WP2526	PDGF pathway	29/3955	39/5488	0.454250538009301	0.898732247244209	0.853487145552281	998/1147/2002/2353/5604/4214/5595/5599/4790/4792/5058/5154/5155/5159/5295/5321/5335/5781/5879/5894/387/6464/6654/6714/6722/6772/6774/7410/8976	29
WP391	Mitochondrial gene expression	13/3955	17/5488	0.462726974113687	0.908986796123683	0.863225447119745	814/1385/2101/2551/2553/50804/4899/10891/133522/5530/23082/51106/64216	13
WP4912	SARS coronavirus and innate immunity	13/3955	17/5488	0.462726974113687	0.908986796123683	0.863225447119745	59272/64135/3454/3455/9641/10379/57506/6772/6773/29110/148022/7098/7187	13
WP3965	Lipid metabolism pathway	18/3955	24/5488	0.476527129300211	0.925093883115454	0.878521651013532	31/47/55902/207/10000/2194/29923/3991/57104/5564/5565/5566/5567/5571/51422/5573/5575/5577	18
WP4856	Intracellular trafficking proteins involved in CMT neuropathy	18/3955	24/5488	0.476527129300211	0.925093883115454	0.878521651013532	1785/1959/121512/54332/3315/23095/9516/9927/4359/8898/10397/5376/8766/5865/5867/53916/10567/81846	18
WP4950	16p11.2 distal deletion syndrome	18/3955	24/5488	0.476527129300211	0.925093883115454	0.878521651013532	11273/930/975/1380/8519/3643/3717/3791/4773/5350/3276/5867/5868/79874/10806/25970/7185/7410	18
WP364	IL6 signaling pathway	31/3955	42/5488	0.478169368194295	0.925093883115454	0.878521651013532	207/572/598/1387/2549/3055/3569/3572/3659/3717/3726/5604/5605/5595/8648/51701/2063/5295/5296/639/5580/5781/5879/6198/6464/9021/6654/6772/6774/7076/7432	31
WP3981	miRNA regulation of prostate cancer signaling pathways	23/3955	31/5488	0.486371682656215	0.925093883115454	0.878521651013532	10000/572/596/842/595/1026/90993/1387/1499/2308/8517/5604/5605/4193/4790/4792/5154/5159/5290/23228/5894/6654/6932	23
WP4752	Base excision repair	23/3955	31/5488	0.486371682656215	0.925093883115454	0.878521651013532	2237/3978/3980/8930/4350/4595/252969/55247/4968/142/10038/11284/5423/5424/5425/10714/5426/5427/54107/56655/27343/23583/6996	23
WP5202	Alstrom syndrome	23/3955	31/5488	0.486371682656215	0.925093883115454	0.878521651013532	81/7840/2647/26258/84984/55125/26052/84062/23432/114928/26160/11020/28981/4645/11159/5989/5990/5991/6608/23557/7029/7283/7415	23
WP2855	Dopaminergic neurogenesis	10/3955	13/5488	0.48657699904627	0.925093883115454	0.878521651013532	1028/1644/3170/2736/4760/5979/6469/6571/6774/7040	10
WP698	Glucuronidation	10/3955	13/5488	0.48657699904627	0.925093883115454	0.878521651013532	3098/5236/55276/5238/5239/7358/7360/54658/54575/79799	10
WP4298	Acute viral myocarditis	54/3955	74/5488	0.489731106736342	0.925093883115454	0.878521651013532	27/60/199/207/596/598/637/663/79886/834/835/836/839/841/842/857/595/1234/920/959/1604/941/54108/1385/1525/1906/1981/2534/3108/3569/3611/3689/51528/3908/5595/100507436/4318/4791/64127/142/5295/6443/6444/8651/6654/6714/6772/6774/7040/148022/7098/7099/7100/7124	54
WP4539	Synaptic signaling pathways associated with autism spectrum disorder	28/3955	38/5488	0.494069273281181	0.925093883115454	0.878521651013532	207/10000/775/814/1742/1978/116443/5595/4763/4893/4915/5290/5291/5295/5296/8503/5564/5565/5571/51422/5728/6009/6198/57521/85358/7248/7249/7337	28
WP2035	Follicle stimulating hormone (FSH) signaling pathway	15/3955	20/5488	0.497740730589293	0.925093883115454	0.878521651013532	207/26060/1385/1978/2308/2870/5595/5566/5894/6009/6194/6198/6446/6714/7249	15
WP2878	PPAR-alpha pathway	15/3955	20/5488	0.497740730589293	0.925093883115454	0.878521651013532	30/34/595/1019/1374/1376/1622/2168/55554/4609/5360/5465/6256/6342/376497	15
WP3580	Methionine de novo and salvage pathway	15/3955	20/5488	0.497740730589293	0.925093883115454	0.878521651013532	55256/262/51074/55349/58478/259307/84245/4482/253827/4507/4953/6611/6723/6898/7295	15
WP3640	Imatinib and chronic myeloid leukemia	15/3955	20/5488	0.497740730589293	0.925093883115454	0.878521651013532	5243/9429/613/1436/2321/1647/3815/4066/4609/4839/5156/5159/5292/11040/200734	15
WP4494	Selective expression of chemokine receptors during T-cell polarization	15/3955	20/5488	0.497740730589293	0.925093883115454	0.878521651013532	6348/6351/1230/729230/1234/920/959/2833/3459/3594/3595/8809/3566/7040/7043	15
WP2355	Corticotropin-releasing hormone signaling pathway	51/3955	70/5488	0.502005913203131	0.928934702381687	0.882169110957437	31/207/408/409/596/673/8912/836/842/1385/1499/2002/2081/2353/2354/2355/2697/2767/2770/2771/2775/2776/2782/2783/2870/3283/3284/3320/3606/3726/3728/5604/4217/5595/5599/5601/10499/4790/4792/4846/142/5335/5336/5580/5894/5908/10411/5970/387/7040/7099	51
WP23	B cell receptor signaling pathway	69/3955	95/5488	0.50317296379008	0.928934702381687	0.882169110957437	207/1386/640/29760/673/695/84433/930/933/973/974/975/998/1147/1380/1385/1399/27071/1871/2002/2308/2534/2549/2931/2969/8517/3608/3662/3932/4067/10892/5604/5605/5608/11184/5599/5601/4208/4209/4609/4690/4773/4775/4790/4792/5170/5294/5295/5296/8394/8395/23396/5335/5336/5580/5781/26469/5879/5894/25780/5966/5970/6195/6452/6464/6654/6850/7006/7410	69
WP2267	Synaptic vesicle pathway	25/3955	34/5488	0.511679783542267	0.933698288956929	0.88669288310555	1175/477/773/2055/8218/1759/10059/1785/26052/4905/11315/246213/6570/6571/6507/6581/291/6532/6804/2054/6809/6812/23025/10497/6844	25
WP4312	Rett syndrome causing genes	25/3955	34/5488	0.511679783542267	0.933698288956929	0.88669288310555	673/1108/8892/2775/10014/55869/3064/3766/10765/4204/4208/9611/23221/23314/6334/85358/6594/6595/6597/6812/23224/9014/79718/8295/56949	25
WP2586	Aryl hydrocarbon receptor pathway	30/3955	41/5488	0.516788147842586	0.933698288956929	0.88669288310555	196/9049/948/11140/1017/1026/1545/1956/2033/2729/27306/3320/4023/5604/4609/135112/4763/4790/1728/4893/8204/84722/5743/5894/5925/5970/5979/6714/7124/7422	30
WP4290	Metabolic reprogramming in colon cancer	30/3955	41/5488	0.516788147842586	0.933698288956929	0.88669288310555	47/50/1743/2023/2194/2539/2597/2618/2744/2821/3101/3418/3419/10606/5211/5223/5226/5230/5315/5471/29968/5831/29920/22934/6472/9123/6510/8801/6888/7086	30
WP363	Wnt signaling pathway	35/3955	48/5488	0.521215837517194	0.933698288956929	0.88669288310555	207/324/409/8312/8313/595/1021/1453/1454/1499/1855/1856/10023/2697/2931/4041/4040/5599/5601/4609/4773/51701/55361/8395/5468/5879/387/4919/4920/6259/6929/6934/7010/7248/7249	35
WP2261	Glioblastoma signaling pathways	58/3955	80/5488	0.522486180762063	0.933698288956929	0.88669288310555	207/10000/369/472/673/675/595/894/898/1017/1019/1021/1026/1030/1956/2033/2064/2065/54206/2260/2263/2308/4303/2549/3667/5604/5605/5606/5607/5608/5609/5595/4193/4194/2956/4763/4893/5156/5159/5170/5286/5287/5290/5291/5294/5295/5296/5335/5336/5580/5590/5728/5894/5925/10253/6714/7248/7249	58
WP3678	Amplification and expansion of oncogenic pathways as metastatic traits	12/3955	16/5488	0.523566146598265	0.933698288956929	0.88669288310555	9595/2034/5294/10631/6714/6932/83439/6934/3371/7412/7422/7428	12
WP368	Mitochondrial long chain fatty acid beta-oxidation	12/3955	16/5488	0.523566146598265	0.933698288956929	0.88669288310555	34/35/80221/2180/2181/2182/1374/1376/1632/3030/55825/6342	12
WP4815	Glycosaminoglycan degradation	12/3955	16/5488	0.523566146598265	0.933698288956929	0.88669288310555	411/2720/2799/3073/3074/138050/10855/60495/3373/8692/3423/4669	12
WP4875	Disruption of postsynaptic signaling by CNV	12/3955	16/5488	0.523566146598265	0.933698288956929	0.88669288310555	818/1739/2332/5595/57555/57502/9378/9379/9369/6804/7082/7532	12
WP299	Nuclear receptors in lipid metabolism and toxicity	17/3955	23/5488	0.527742511149568	0.933698288956929	0.88669288310555	19/5243/5244/1244/5825/9619/64240/1594/1555/1576/8856/5465/5467/5468/5914/5916/7421	17
WP4719	Eicosanoid metabolism via cyclooxygenases (COX)	17/3955	23/5488	0.527742511149568	0.933698288956929	0.88669288310555	30/51/8309/231/66002/8529/3248/5321/8398/5467/5729/5730/9536/5737/5742/5743/6916	17
WP4767	FGFR3 signaling in chondrocyte proliferation and terminal differentiation	17/3955	23/5488	0.527742511149568	0.933698288956929	0.88669288310555	650/1026/1267/2254/2261/3549/5604/5605/5600/6300/5603/5595/4882/5894/6662/6772/7067	17
WP1544	MicroRNAs in cardiomyocyte hypertrophy	55/3955	76/5488	0.535051653958507	0.943605472795834	0.896101307117325	207/1022/1147/1154/1499/1855/1906/2247/2263/9759/10014/51564/9734/3479/9641/8517/3572/3976/4041/4040/5604/5605/5606/5607/5608/5609/9020/5595/5599/50804/4638/4776/4790/3084/5170/5290/5291/5294/5295/5296/8503/5320/5330/5530/5532/5592/5879/5894/1827/387/9475/6774/7040/7124/7474	55
WP4204	Tumor suppressor activity of SMARCB1	19/3955	26/5488	0.553983292629028	0.949375016666849	0.901580393402156	86/8289/57492/1019/1021/8110/8726/2736/2737/2738/5925/5928/6597/6598/6601/6602/6604/6608/23512	19
WP4838	Regucalcin in proximal tubule epithelial kidney cells	19/3955	26/5488	0.553983292629028	0.949375016666849	0.901580393402156	59/207/578/673/836/841/842/10146/4217/90550/5153/5290/5894/5970/4089/7040/7046/7132/8600	19
WP5038	Mitochondrial immune response to SARS-CoV-2	19/3955	26/5488	0.553983292629028	0.949375016666849	0.901580393402156	28976/1636/59272/1514/51295/64135/9641/3665/57506/51103/4790/4791/27035/29110/148022/7098/7113/7187/7189	19
WP5102	Familial partial lipodystrophy (FPLD)	19/3955	26/5488	0.553983292629028	0.949375016666849	0.901580393402156	8815/63924/2339/2624/2625/688/3991/4000/4001/84823/4023/5601/11343/5290/57104/5465/5468/5396/6777	19
WP5122	Prostaglandin and leukotriene metabolism in senescence 	19/3955	26/5488	0.553983292629028	0.949375016666849	0.901580393402156	246/241/1026/10800/2770/2776/3488/5600/5321/23236/5730/5732/5734/9536/5742/5743/5925/23411/6916	19
WP4141	PI3K/AKT/mTOR - vitamin D3 signaling	14/3955	19/5488	0.554146265245634	0.949375016666849	0.901580393402156	207/941/942/3101/3122/4609/5210/5290/5970/6256/6515/7248/7249/7421	14
WP4534	Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms	29/3955	40/5488	0.55599328919124	0.949375016666849	0.901580393402156	59/60/72/999/1499/3688/3689/3690/3691/3693/3694/3696/11184/5871/9448/5602/5599/5601/4485/5058/5062/10298/60485/259230/6714/6788/7003/8463/7004	29
WP4917	Proximal tubule transport	29/3955	40/5488	0.55599328919124	0.949375016666849	0.901580393402156	5243/1244/10257/9429/358/476/533/523/528/51382/9296/9550/760/762/6560/6505/6575/65010/6514/142680/6519/55244/6522/8671/160728/340024/9056/11136/6550	29
WP1602	Nicotine effect on dopaminergic neurons	9/3955	12/5488	0.556891769677198	0.949375016666849	0.901580393402156	1020/1138/1644/2770/2782/3777/5499/5566/6571	9
WP2513	Nanoparticle triggered regulated necrosis	9/3955	12/5488	0.556891769677198	0.949375016666849	0.901580393402156	841/5599/142/5321/11035/148022/7124/7132/8717	9
WP4879	Overlap between signal transduction pathways contributing to LMNA laminopathies	34/3955	47/5488	0.557423973559328	0.949375016666849	0.901580393402156	60/27161/324/8312/650/1019/1026/1051/1052/1387/1499/1513/2010/2339/3726/8850/23592/4000/4128/4129/4673/5468/5925/860/4088/6696/6895/6932/83439/6934/7040/7088/7112/4982	34
WP2018	RANKL/RANK signaling pathway	39/3955	54/5488	0.558961739885373	0.949375016666849	0.901580393402156	54/207/998/1147/1513/2274/2353/3383/8517/4067/5604/5608/5609/5595/5599/5601/4286/4772/4790/4791/4792/9060/5295/5296/5335/5879/5970/6688/6714/6772/6850/8792/4982/8600/7185/7187/7188/7189/7412	39
WP4538	Regulatory circuits of the STAT3 signaling pathway	49/3955	68/5488	0.562163444444192	0.951884114519	0.903963175115298	84335/1271/1387/1438/1439/1441/64798/1844/1956/2149/2151/9002/2690/3454/3455/3459/163702/3587/3595/3601/53832/58985/3559/3560/3561/3563/3572/3575/3717/5602/5600/6300/5603/5595/5597/5599/5601/9180/5156/5159/10401/5789/253260/57521/80854/9021/6714/6774/3925	49
WP4657	22q11.2 copy number variation syndrome	59/3955	82/5488	0.565387266118689	0.952806290288501	0.904838925560018	59/150209/8854/8659/406/421/25842/596/128977/23468/998/8646/9076/1365/7122/8218/1312/1399/8452/56603/9681/9993/85359/54487/1956/284361/2260/2263/3170/8479/84861/3837/10892/64976/9611/8131/4942/10298/5297/5347/5625/5894/5901/5902/5905/9978/1104/5649/6097/57142/6469/8036/6576/6545/6721/6722/27037/7450/7514	59
WP1541	Energy metabolism	31/3955	43/5488	0.575584991664438	0.952806290288501	0.904838925560018	1386/818/814/1385/2033/2101/2308/2551/4208/4209/10514/8648/4899/5465/5467/5468/10891/133522/5530/5532/23082/5564/5565/5571/51422/3276/6256/23411/23410/51106/64216	31
WP4329	miRNAs involvement in the immune response in sepsis	26/3955	36/5488	0.575991786900417	0.952806290288501	0.904838925560018	6348/6351/1147/3002/3383/8517/3552/3569/3654/3659/3663/3665/3934/5599/406937/4790/4791/4792/5966/5970/7099/51311/7124/7187/7189/7412	26
WP2374	Oncostatin M signaling pathway	46/3955	64/5488	0.576849153613168	0.952806290288501	0.904838925560018	207/836/6347/1017/1051/1385/1958/2353/3091/3572/3667/3717/3726/3949/5604/5605/5595/5599/5601/4312/4322/4314/4790/4792/5008/9180/10401/5295/5580/5581/2185/5781/5894/5970/253260/6194/5054/6464/9021/6654/6714/6772/6774/6777/7078/7422	46
WP3972	PDGFR-beta pathway	21/3955	29/5488	0.577294126505783	0.952806290288501	0.904838925560018	5610/2002/2353/3717/5604/4214/5595/5599/5159/5290/5295/5335/5894/6464/6654/6722/6772/6774/6776/6777/6778	21
WP3612	Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling	16/3955	22/5488	0.580262628269501	0.952806290288501	0.904838925560018	1244/10257/368/9429/1066/2052/2353/2729/2950/3162/5600/6300/5603/5599/1728/4835	16
WP430	Statin inhibition of cholesterol production	16/3955	22/5488	0.580262628269501	0.952806290288501	0.904838925560018	19/64240/84532/338/341/348/8694/2222/3156/3949/4023/4035/5360/949/6646/6713	16
WP4483	Relationship between inflammation, COX-2 and EGFR	16/3955	22/5488	0.580262628269501	0.952806290288501	0.904838925560018	207/10000/673/1956/5595/4312/4893/5290/5291/5294/51365/5732/5734/80142/5743/6714	16
WP4721	Eicosanoid metabolism via lipooxygenases (LOX)	16/3955	22/5488	0.580262628269501	0.952806290288501	0.904838925560018	30/51/8309/246/66002/8529/10800/57105/1800/2358/2687/3248/1241/5465/5467/8989	16
WP231	TNF-alpha signaling pathway	66/3955	92/5488	0.580695611792694	0.952806290288501	0.904838925560018	207/572/598/637/329/330/8945/836/841/842/6347/11140/8837/1147/1387/1457/8454/1535/56616/2752/3320/8517/3569/8844/283455/8567/5606/5608/5609/4214/9020/4215/4217/1326/5871/5595/5599/5601/4790/4791/4792/27035/124056/4893/56957/5347/5590/5790/5836/5879/5894/5966/11035/6401/6654/257397/10010/29110/7124/7128/7132/7133/8717/7185/10131/7295	66
WP3	Transcriptional activation by NRF2 in response to phytochemicals	11/3955	15/5488	0.586873439670453	0.952806290288501	0.904838925560018	7965/1051/2048/2729/2939/3162/4094/5599/1728/5290/23657	11
WP3927	BMP signaling in eyelid development	11/3955	15/5488	0.586873439670453	0.952806290288501	0.904838925560018	1956/2263/4214/5595/5601/6422/6469/4086/4089/4090/7039	11
WP5074	Kallmann syndrome	11/3955	15/5488	0.586873439670453	0.952806290288501	0.904838925560018	207/55636/2260/10818/5605/5290/23129/60675/5781/9723/26022	11
WP5149	Lipid metabolism in senescent cells	11/3955	15/5488	0.586873439670453	0.952806290288501	0.904838925560018	1026/8399/81579/84647/5321/8605/255189/8398/7941/5743/6578	11
WP4535	Envelope proteins and their potential roles in EDMD physiopathology	28/3955	39/5488	0.595426053973238	0.963856838103306	0.915333152889867	107/196883/111/112/113/115/8815/2010/3799/23592/5604/5605/4293/5595/4893/5339/387/4088/4089/6654/6655/6722/23353/23224/7040/7043/79188/7112	28
WP4542	Leukocyte-intrinsic Hippo pathway functions	23/3955	32/5488	0.598254601614955	0.965603918396068	0.91699227948368	930/83706/2308/4303/50943/90417/26524/4023/55233/4485/10397/639/5872/5879/83593/387/60485/6788/7003/8463/7004/81671/10413	23
WP673	ErbB signaling pathway	55/3955	77/5488	0.606583935598091	0.974153894239967	0.925111821761067	27/207/10000/369/572/10018/673/685/818/868/595/1026/1399/1956/1978/2002/2064/2065/2308/2549/1839/5604/5605/5609/5602/5595/5599/5601/4193/4609/4690/8440/4893/3084/5058/5062/10298/5170/5290/5291/5295/5296/8503/5335/5336/5894/6198/6464/25759/6654/6655/6714/6776/6777/7039	55
WP4803	Ciliopathies	90/3955	126/5488	0.608283359165918	0.974153894239967	0.925111821761067	112/54806/122481/7840/203286/200894/23568/403/84100/27077/92482/166379/583/55212/57545/79140/9731/22897/84984/80184/95681/84131/23059/1259/51473/83479/55172/83544/79659/2121/201163/2622/2736/2737/84662/23432/55764/9742/26160/11020/112752/51098/55081/28981/27152/27130/9657/9851/167691/54585/8195/54903/4751/284086/29922/261734/4952/8481/5311/25886/282809/51715/6102/23322/89765/83861/132320/10806/6608/6674/55812/202018/79600/79867/84314/79583/65062/91147/10210/22954/146057/79809/123016/7275/8239/51057/57728/57539/63929/23090	90
WP437	EGF/EGFR signaling pathway	110/3955	154/5488	0.610880523980923	0.974153894239967	0.925111821761067	10006/207/1175/382/50807/466/6790/9564/673/857/858/868/23624/998/1385/1399/1445/1759/9046/1956/1978/2002/29924/2060/58513/2059/2064/54206/2353/2354/2308/4303/2549/2697/2887/8826/9922/83737/3717/3985/5604/5605/5607/4214/10746/4215/4216/11184/5599/5601/4208/4209/4605/4690/8440/8202/4738/4846/5058/5170/5037/10401/5287/5295/5296/51196/5335/5337/5338/5359/5580/5590/5728/2185/5753/5781/5782/5801/7837/5868/5879/5894/5898/5899/10928/5900/253260/9610/6195/6196/6198/9047/30011/6464/6654/6655/10253/6714/8027/10617/6772/6774/6776/6777/3925/6812/8867/9712/7410/10451	110
WP4533	Transcription co-factors SKI and SKIL protein partners	13/3955	18/5488	0.611807967380503	0.974153894239967	0.925111821761067	3622/26524/4204/10461/4763/10419/23314/25942/6497/6788/7003/8463/7004	13
WP4255	Non-small cell lung cancer	47/3955	66/5488	0.622271569738891	0.974153894239967	0.925111821761067	207/10000/369/572/578/637/673/836/841/842/595/1019/1021/1026/1643/1870/1871/1956/2064/1647/4616/10912/5604/5605/5595/4893/5163/5290/5291/5295/5296/8503/5335/5336/51426/5894/11186/83593/5925/6256/6257/6654/6655/6774/6776/6777/7039	47
WP143	Fatty acid beta-oxidation	20/3955	28/5488	0.623358468048439	0.974153894239967	0.925111821761067	34/35/38/2180/2181/2182/51703/23305/55902/1374/1376/1384/1892/1632/2639/3030/3032/3991/4023/57104	20
WP4241	Type 2 papillary renal cell carcinoma	20/3955	28/5488	0.623358468048439	0.974153894239967	0.925111821761067	9915/1026/1387/1513/1856/54583/112399/2033/2034/3091/5155/9978/29072/7030/7942/7039/7040/7043/7422/7428	20
WP4211	Transcriptional cascade regulating adipogenesis	8/3955	11/5488	0.630056898377786	0.974153894239967	0.925111821761067	1051/1052/1054/1959/2624/2625/688/5468	8
WP4271	Vitamin B12 disorders	8/3955	11/5488	0.630056898377786	0.974153894239967	0.925111821761067	81693/51293/8029/166785/25974/27249/6947/6948	8
WP4504	Cysteine and methionine catabolism	8/3955	11/5488	0.630056898377786	0.974153894239967	0.925111821761067	875/51380/1491/23474/2729/2805/4357/6821	8
WP4947	Nitric oxide metabolism in cystic fibrosis	8/3955	11/5488	0.630056898377786	0.974153894239967	0.925111821761067	23564/4843/4846/3276/10196/10419/55170/54496	8
WP5049	Glycolysis in senescence	8/3955	11/5488	0.630056898377786	0.974153894239967	0.925111821761067	230/2023/2539/2597/3098/5230/5315/5925	8
WP692	Sulfation biotransformation reaction	8/3955	11/5488	0.630056898377786	0.974153894239967	0.925111821761067	2539/2936/9061/9060/6799/27284/6819/6820	8
WP2509	Nanoparticle triggered autophagic cell death	15/3955	21/5488	0.633252930101998	0.974153894239967	0.925111821761067	83734/55054/64422/115201/10533/596/3643/84557/51100/7248/7249/8408/9706/7405/81671	15
WP4905	1q21.1 copy number variation syndrome	15/3955	21/5488	0.633252930101998	0.974153894239967	0.925111821761067	1499/2330/2697/2702/149013/100506658/5564/5565/5571/51422/26108/90780/7082/9414/27134	15
WP707	DNA damage response	44/3955	62/5488	0.638352085926729	0.974153894239967	0.925111821761067	472/545/84126/27113/637/836/841/842/891/595/894/898/9134/993/1017/1019/1020/1021/1026/1111/11200/1385/1643/355/1647/4616/10912/4193/4609/4683/5366/5371/5884/10111/5893/5883/5925/5981/50484/27244/2810/9874/11011/8795	44
WP1403	AMP-activated protein kinase (AMPK) signaling	39/3955	55/5488	0.641366460665344	0.974153894239967	0.925111821761067	31/32/79602/207/51719/84254/10645/890/891/1026/1374/1938/29904/1978/2194/3156/3172/3643/3953/3991/5209/5290/5291/5294/5295/5296/8503/23236/133522/5564/5565/5567/5571/51422/6198/57521/55437/7248/7249	39
WP183	Proteasome degradation	39/3955	55/5488	0.641366460665344	0.974153894239967	0.925111821761067	3105/3106/3107/3133/3134/3135/5682/5683/5684/5685/5686/5687/5689/5699/5690/5691/5692/5693/5694/5696/5698/5701/5704/5707/5716/5717/5718/5719/9861/5713/5720/5721/10197/6184/6185/7318/7314/7316/7321	39
WP3414	Initiation of transcription and translation elongation at the HIV-1 LTR	22/3955	31/5488	0.641608165940691	0.974153894239967	0.925111821761067	1387/2033/3066/9759/10014/51564/55869/9734/10614/7469/25920/51497/4772/4773/4775/4776/4790/4792/5530/5532/5970/6829	22
WP4756	Renin-angiotensin-aldosterone system (RAAS)	22/3955	31/5488	0.641608165940691	0.974153894239967	0.925111821761067	1636/466/1386/468/8536/57118/818/814/1215/1385/10488/90993/84699/148327/9586/1511/2776/3283/3284/3708/3710/5330	22
WP4549	Fragile X syndrome	66/3955	93/5488	0.643913375504793	0.974153894239967	0.925111821761067	18/5825/27161/9495/207/84335/224/7915/1175/351/369/9743/673/8536/814/8218/1268/1374/1385/26999/64798/1742/1759/1785/1915/1977/1979/1981/2043/2332/2534/2549/23426/3708/4131/5604/5605/4204/8569/4318/4763/4915/5163/5291/23236/5335/5499/5526/5530/5566/5573/5728/5781/5894/6009/6198/57521/6464/6654/6714/6895/51256/9524/9894/7248/7249	66
WP3286	Copper homeostasis	34/3955	48/5488	0.645358018233081	0.974153894239967	0.925111821761067	102/6868/8754/207/324/351/475/538/23621/836/595/150684/1353/2308/4193/4493/4494/4495/4496/22823/5290/5621/5728/6341/4891/1317/1318/6647/6649/26872/261729/55240/79689/54739	34
WP4582	Cancer immunotherapy by CTLA4 blockade	10/3955	14/5488	0.651280519768889	0.974153894239967	0.925111821761067	941/942/1493/3123/5290/5291/5295/5296/8503/5781	10
WP5061	Fatty acid transporters	10/3955	14/5488	0.651280519768889	0.974153894239967	0.925111821761067	2180/2181/2182/51703/23305/948/1622/2168/2171/10999	10
WP5101	Congenital generalized lipodystrophy (CGL)	10/3955	14/5488	0.651280519768889	0.974153894239967	0.925111821761067	10555/857/8694/2534/3091/3667/3691/23175/64900/5290	10
WP1530	miRNA regulation of DNA damage response	46/3955	65/5488	0.651864943838068	0.974153894239967	0.925111821761067	472/545/84126/27113/637/836/841/842/891/595/894/898/9134/900/993/1017/1019/1020/1021/1026/1111/11200/1385/1643/355/1647/4616/10912/4193/406937/4609/4683/5366/5371/5884/10111/5893/5883/5925/5981/50484/27244/2810/9874/11011/8795	46
WP2406	Cardiac progenitor differentiation	17/3955	24/5488	0.652122724212293	0.974153894239967	0.925111821761067	649/2247/3170/3479/3481/3624/3791/3815/4208/4684/3084/5156/5460/4920/140885/7040/7070	17
WP2853	Endoderm differentiation	78/3955	110/5488	0.652965472588384	0.974153894239967	0.925111821761067	31/324/351/10973/57198/63035/655/657/2186/708/9425/11190/23373/1488/1499/8450/1601/23181/1844/1846/1847/8320/57669/3169/3170/1112/2308/2627/2736/79977/6928/3198/9682/3915/10128/10459/5606/54799/22823/80155/54892/51701/4830/2908/54623/79668/5087/5090/84295/23007/5460/23682/5916/64864/27244/51460/6422/6478/154091/4088/4089/83595/6772/6877/30009/6932/83439/7040/57690/27324/55809/85363/51366/10451/115825/7473/23286/23528	78
WP4249	Hedgehog signaling pathway	24/3955	34/5488	0.65819978200417	0.976798126062802	0.9276229343617	408/409/596/91653/595/894/50937/1453/1454/8452/2121/64839/2619/2736/2737/23432/64399/3549/5566/5567/6469/6608/64750/339745	24
WP2032	Thyroid stimulating hormone (TSH) signaling pathway	43/3955	61/5488	0.6684818034588	0.976798126062802	0.9276229343617	207/673/898/1017/1019/1385/1958/2353/2768/10672/2770/2771/2773/2775/2776/2782/3717/5604/5606/5608/5595/4609/7849/5144/5170/5290/5295/5296/23236/5337/5894/5900/5908/5925/5934/6194/6195/6198/23513/6714/6772/6774/7270	43
WP2643	Nanoparticle-mediated activation of receptor signaling	19/3955	27/5488	0.669001489394059	0.976798126062802	0.9276229343617	10000/1277/1956/2335/3672/3688/5604/5605/5602/5600/6300/5603/5599/5601/4893/5894/6654/6714/7094	19
WP3996	Ethanol effects on histone modifications	19/3955	27/5488	0.669001489394059	0.976798126062802	0.9276229343617	55902/125/8854/220/1386/1719/10919/55140/8520/3066/9759/10014/10013/51564/55869/9734/8850/4524/7298	19
WP408	Oxidative stress response	19/3955	27/5488	0.669001489394059	0.976798126062802	0.9276229343617	847/1536/2353/2729/2876/2878/2936/3162/3726/4128/5602/4784/4790/27035/1728/6647/6648/6649/25828	19
WP4561	Cell migration and invasion through p75NTR	19/3955	27/5488	0.669001489394059	0.976798126062802	0.9276229343617	11093/207/10000/375/1009/1942/1944/1945/1946/1949/57498/4313/4318/4804/4915/5058/5879/387/6774	19
WP4560	MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement	12/3955	17/5488	0.669580160561253	0.976798126062802	0.9276229343617	87/1385/3685/3690/3708/4026/5595/8076/4638/5335/7082/7414	12
WP734	Serotonin receptor 4/6/7 and NR3C signaling	12/3955	17/5488	0.669580160561253	0.976798126062802	0.9276229343617	466/673/1385/1958/2002/3360/5604/5605/5595/9261/2908/6722	12
WP69	T-cell receptor signaling pathway	60/3955	85/5488	0.670687341320321	0.976798126062802	0.9276229343617	207/1386/84433/868/1234/920/998/1147/1385/1399/355/2353/2534/2625/9402/29851/8517/3601/3552/3553/3569/3662/3708/3932/3937/10892/5604/5605/9020/1326/11184/5595/5599/5601/4690/4772/4773/4790/4792/5058/5170/5295/5296/5335/5580/9051/2185/5781/5894/5966/5970/8767/10019/6464/6654/7040/7189/10451/7431/7454	60
WP3915	Angiopoietin-like protein 8 regulatory pathway	87/3955	123/5488	0.672433492579465	0.976798126062802	0.9276229343617	64240/207/10487/868/23624/1555/1576/1734/1977/1978/2194/2203/10211/2308/2931/3643/3667/8660/4023/5604/5605/5606/5607/5608/5609/4214/4296/7786/9175/9020/10746/4215/4216/4217/9064/1326/4293/11184/5871/9448/5602/5600/6300/5603/5595/5597/5599/5601/50488/51085/5105/5170/5286/5290/5291/5294/5295/5296/8503/5564/5565/5571/51422/5770/5894/6009/23433/253260/6195/6196/8986/27330/6198/57521/6256/6319/143686/6464/25759/6567/6654/6655/6721/7067/7068/7248/7249	87
WP3929	Chemokine signaling pathway	99/3955	140/5488	0.679730121106413	0.97699644656184	0.927811270762388	107/196883/111/112/113/115/207/10000/408/409/9564/673/6356/6363/6364/6367/6369/56477/6348/6351/1230/729230/10803/998/1147/1399/1445/6376/3627/6373/6387/58191/2921/6374/4283/3579/2833/643/10663/2268/2770/2771/2773/2782/2783/59345/2791/55970/2786/2787/2869/2870/3055/8517/3717/4067/5604/5595/4790/4792/4893/5058/5290/5291/5294/5295/5296/8503/23533/23236/5330/5331/5332/57580/5567/5580/5590/5613/2185/5879/5894/5908/5970/9475/6464/25759/6654/6655/6772/6773/6774/6777/26230/7410/10451/7454/8976/6375/2829	99
WP2371	Parkinson's disease pathway	21/3955	30/5488	0.684286297134108	0.97699644656184	0.927811270762388	835/836/839/842/898/9134/1644/120892/5600/6300/5603/11315/65018/9627/23208/7318/7314/7326/51465/7332/9246	21
WP4871	Kisspeptin/kisspeptin receptor system in the ovary	21/3955	30/5488	0.684286297134108	0.97699644656184	0.927811270762388	207/408/409/3283/5604/5605/5595/4318/4790/4893/5163/5290/5291/5294/23236/5330/5331/5332/5580/5581/5894	21
WP3651	Pathways affected in adenoid cystic carcinoma	40/3955	57/5488	0.685975915400692	0.97699644656184	0.927811270762388	207/8289/51742/84159/472/54880/63035/23774/1111/11200/55783/1387/23220/2033/2064/55294/93986/221037/284058/7994/7403/58508/9223/55534/5605/23269/4603/4609/26292/9611/4781/64324/5290/5728/5894/29072/6595/10847/9874/29128	40
WP702	Metapathway biotransformation Phase I and II	74/3955	105/5488	0.687312210308141	0.97699644656184	0.927811270762388	231/57016/1645/22977/50515/55501/113189/9435/9469/23563/1312/1545/57404/56603/1593/1594/1555/1558/1573/120227/29785/113612/1576/1577/1551/57834/66002/8529/4051/285440/1595/9420/2052/2053/2326/2329/2330/9514/64090/79690/2877/2878/2879/2936/2938/2939/79807/2947/9446/2950/2954/9653/9957/9953/9394/11185/4259/51126/122830/79829/55226/57106/10/9027/26151/3340/4837/6799/27284/6819/6820/54658/54575/79799	74
WP422	MAPK cascade	23/3955	33/5488	0.69826021363438	0.97699644656184	0.927811270762388	369/673/2002/5604/5605/5606/5608/5609/4214/7786/10746/4215/5602/6300/5595/4155/4893/5331/5894/22821/6237/6654/6655	23
WP531	DNA mismatch repair	16/3955	23/5488	0.700308610257918	0.97699644656184	0.927811270762388	9156/3978/4292/4436/2956/5395/5424/5425/10714/5426/5427/54107/56655/5981/5982/6117	16
WP410	Exercise-induced circadian regulation	30/3955	43/5488	0.700450724576105	0.97699644656184	0.927811270762388	406/51582/694/11335/1051/7122/9575/1408/3301/2120/50486/2674/2947/2950/9709/3108/3422/10787/8031/9975/5187/8864/5281/5507/5685/5813/9444/11030/7360/9218	30
WP1425	Bone morphogenic protein (BMP) signaling and regulation	7/3955	10/5488	0.70387570834244	0.97699644656184	0.927811270762388	650/657/659/860/4086/4089/10766	7
WP2815	Mammary gland development pathway - Involution (Stage 4 of 4)	7/3955	10/5488	0.70387570834244	0.97699644656184	0.927811270762388	999/1116/3572/4318/4609/9021/6774	7
WP2879	Farnesoid X receptor pathway	7/3955	10/5488	0.70387570834244	0.97699644656184	0.927811270762388	5244/1576/8660/8431/10891/6256/11309	7
WP4942	15q13.3 copy number variation syndrome	7/3955	10/5488	0.70387570834244	0.97699644656184	0.927811270762388	1139/1387/22909/2534/8850/51621/871	7
WP5104	Acquired partial lipodystrophy / Barraquer-Simons syndrome	7/3955	10/5488	0.70387570834244	0.97699644656184	0.927811270762388	727/629/1675/2339/4000/4001/84823	7
WP5110	Familial hyperlipidemia type 3	7/3955	10/5488	0.70387570834244	0.97699644656184	0.927811270762388	348/3949/4023/4035/5360/949/7436	7
WP5118	SMC1/SMC3 role in DNA damage - Cornelia de Lange Syndrome	7/3955	10/5488	0.70387570834244	0.97699644656184	0.927811270762388	472/9656/4683/22976/56852/10111/9126	7
WP5187	mRNA vaccine activation of dendritic cell and induction of IFN-1	7/3955	10/5488	0.70387570834244	0.97699644656184	0.927811270762388	64135/3665/57506/3140/7098/51311/8792	7
WP2882	Nuclear receptors meta-pathway	177/3955	250/5488	0.703937440981475	0.97699644656184	0.927811270762388	5243/5244/1244/10257/64240/11057/30/34/51/196/9049/11214/211/218/241/221079/84002/8553/329/330/645/873/874/6347/6364/595/11140/1019/1028/1066/8824/80315/1374/1376/8454/1545/1555/1576/1577/1551/66002/1622/1907/1956/1958/8507/2033/54566/1969/2042/2168/2194/121512/2258/9982/2308/2539/4616/2729/2678/57678/387509/2877/2878/2936/2938/2939/2947/2950/1839/3082/3162/3320/3589/3553/8660/3726/8850/55554/56262/23764/4199/4240/4259/4609/26509/8648/10499/8202/23054/4791/1728/8431/8856/2908/3084/8204/5105/5142/5155/5166/5226/10769/5360/51426/5460/5465/5467/10891/5052/9588/79056/5743/5997/6256/6319/6337/6342/6397/5265/5272/9792/1836/376497/81031/66035/154091/6514/6515/6518/11182/29988/27173/91252/23516/29985/283375/25800/7922/64116/115584/159963/6527/8884/160728/200010/11254/340024/6532/6533/6534/6535/23657/8140/11309/6594/6591/6649/10252/6714/5552/27286/6774/2040/7039/7040/7048/7049/7056/7124/7128/84951/1831/7295/114112/54658/7421	177
WP2795	Cardiac hypertrophic response	37/3955	53/5488	0.704428597339877	0.97699644656184	0.927811270762388	207/1022/1147/2247/2263/9759/10014/51564/9734/3479/9641/8517/5604/5605/5606/5607/5608/5609/4214/9020/11184/5595/5599/4773/4790/3084/5170/5320/5530/5587/5592/5879/5894/7040/7046/7124/7132	37
WP3594	Circadian rhythm genes	100/3955	142/5488	0.707569840344289	0.978893613709392	0.929612928351024	107/196/9915/406/56938/468/22809/8553/79365/114781/8945/1019/1364/9575/1374/1385/1390/23373/1408/1453/1454/8454/1628/1644/1655/1660/1859/1958/2033/355/26224/2767/2776/3066/50865/6928/3184/3398/3399/3569/3778/5927/4297/55366/9500/5602/5599/5601/9112/10514/4669/10135/10499/9611/4783/4804/4843/4862/9572/9975/2063/8204/23596/5187/8864/23239/5371/5465/5468/10891/5499/5501/5551/5593/10419/60675/55269/5728/5730/10743/5936/83759/9475/6095/6097/5054/25942/23411/6532/6550/6839/79723/8792/7150/7166/7298/7316/7337/9099/463	100
WP254	Apoptosis	56/3955	80/5488	0.709810721523941	0.979491816341008	0.930181015518349	207/572/578/27113/596/598/10018/599/637/329/330/332/665/666/834/843/835/836/837/839/841/842/8837/1147/8738/56616/355/356/3002/3479/3481/8517/3659/3662/3663/3664/3665/4049/4214/5602/4170/4193/4609/4790/4792/5295/5366/5551/5970/7124/8795/7132/7133/8717/7185/7187	56
WP3591	Sleep regulation	9/3955	13/5488	0.715100003596787	0.979491816341008	0.930181015518349	114781/1737/2353/3606/3569/4862/5729/5730/2030	9
WP4522	Metabolic pathway of LDL, HDL and TG, including diseases	9/3955	13/5488	0.715100003596787	0.979491816341008	0.930181015518349	19/302/338/348/3949/9388/4023/255738/949	9
WP5178	Disorders of fructose metabolism	9/3955	13/5488	0.715100003596787	0.979491816341008	0.930181015518349	2203/132158/2821/3098/3795/5211/5236/6514/6652	9
WP399	Wnt signaling pathway and pluripotency	53/3955	76/5488	0.724516035653157	0.984851389201364	0.935270770065369	324/8312/8313/595/894/960/1387/1454/1488/1499/1500/1855/1856/2033/26190/10023/7976/8322/7855/8323/8324/8325/3949/4041/4040/120892/5602/5601/4316/4609/51701/5048/5328/5460/5467/5519/5523/28227/5529/5580/5581/5590/5587/29127/387/6932/83439/6934/7482/7473/54361/7474/81029	53
WP2011	SREBF and miR33 in cholesterol and lipid homeostasis	11/3955	16/5488	0.726149484429267	0.984851389201364	0.935270770065369	19/2194/3156/3157/3949/5465/10891/6319/23411/51548/6721	11
WP3287	Overview of nanoparticle effects	11/3955	16/5488	0.726149484429267	0.984851389201364	0.935270770065369	10000/596/1001/1282/2335/3162/3569/4798/5742/5743/7124	11
WP4478	LTF danger signal response pathway	11/3955	16/5488	0.726149484429267	0.984851389201364	0.935270770065369	929/3552/3553/3569/3654/4790/7097/7099/7124/7189/54210	11
WP4585	Cancer immunotherapy by PD-1 blockade	15/3955	22/5488	0.746803576885919	0.999999999999396	0.949656750571509	10538/29126/926/3105/3123/3932/4772/4773/4775/4776/4790/5133/80380/5781/6774	15
WP2516	ATM signaling pathway	24/3955	35/5488	0.747468691958157	0.999999999999396	0.949656750571509	1386/472/637/835/891/898/993/1017/1026/1111/11200/8738/1385/1647/8517/5601/9656/4193/4194/4683/4792/10111/5883/9874	24
WP5130	Th17 cell differentiation pathway	40/3955	58/5488	0.754090455229015	0.999999999999396	0.949656750571509	196/406/920/9575/2353/50943/2625/3091/3108/3320/3459/3553/3559/3566/3569/3662/3717/3932/5599/4772/4783/4790/4792/9572/5187/5335/5530/5914/6095/6097/861/6256/9021/6772/6774/6776/6778/30009/7040/7046	40
WP2272	Pathogenic Escherichia coli infection	33/3955	48/5488	0.754340630255054	0.999999999999396	0.949656750571509	60/10095/10094/81873/929/998/999/9076/1499/2017/7430/2534/3688/23643/4690/8440/4691/100506658/387/9475/7099/7100/7846/10376/7277/79861/7280/347733/10383/84617/7454/8976/7534	33
WP5224	2q37 copy number variation syndrome	66/3955	95/5488	0.755536275311682	0.999999999999396	0.949656750571509	19/116987/51281/50636/375/10123/51665/23192/666/10203/1058/8837/1293/6373/6387/9265/27128/728294/8527/27185/1841/285193/1915/1956/11337/11345/64090/10691/2817/2859/9759/3069/55502/3597/3553/3611/84289/3690/3705/84557/81631/4134/4208/151507/4644/4738/129807/4792/5133/5154/8864/64284/5873/5879/10267/6194/10670/64121/58528/23677/25992/7124/7187/140739/54658/54575	66
WP5121	Sphingolipid metabolism in senescence	17/3955	25/5488	0.756334403458478	0.999999999999396	0.949656750571509	427/1017/1019/1026/29956/79603/8560/2720/2531/23236/5925/1901/166929/81537/55512/8877/7357	17
WP2864	Apoptosis-related network due to altered Notch3 in ovarian cancer	35/3955	51/5488	0.763536532287413	0.999999999999396	0.949656750571509	207/308/348/351/8312/602/332/1026/8454/8065/2065/2081/2149/2729/3309/3315/8870/3575/10276/4790/1728/3084/5062/2185/8767/6198/4092/9021/7057/7124/8795/7185/10451/7431/8531	35
WP4205	MET in type 1 papillary renal cell carcinoma	35/3955	51/5488	0.763536532287413	0.999999999999396	0.949656750571509	207/10000/369/572/673/998/1026/1399/2549/3082/5604/5605/5595/5599/4893/5058/5062/10298/5290/5291/5295/5296/8503/5335/5781/5879/5894/5908/6135/6654/6655/6714/6774/6801/7030	35
WP314	Fas ligand pathway and stress induction of heat shock proteins	28/3955	41/5488	0.766475080648751	0.999999999999396	0.949656750571509	60/596/843/836/839/841/842/8837/1616/355/356/3315/3552/4000/4001/84823/4214/5599/9261/7867/4799/5058/5062/142/5925/8767/6709/7124	28
WP4536	Genes related to primary cilium development (based on CRISPR)	58/3955	84/5488	0.773852990643228	0.999999999999396	0.949656750571509	200894/403/84100/80210/27077/166379/583/55212/25776/57545/23552/9731/84984/55125/80817/79959/23059/79659/6993/2121/55764/9742/26160/11020/112752/56912/51098/55081/28981/10300/9851/9371/22920/54585/8195/54903/8481/51715/11159/23322/163786/132320/79600/79867/84314/79583/91147/146057/79809/79989/150737/123016/51175/7289/79770/51057/57728/57539	58
WP3301	MFAP5-mediated ovarian cancer cell motility and invasiveness	8/3955	12/5488	0.776387155778963	0.999999999999396	0.949656750571509	1385/3685/3690/3710/5595/8076/5335/7134	8
WP4190	Mevalonate arm of cholesterol biosynthesis pathway	8/3955	12/5488	0.776387155778963	0.999999999999396	0.949656750571509	38/39/2222/3156/3157/3422/4598/10654	8
WP5109	Familial hyperlipidemia type 2	8/3955	12/5488	0.776387155778963	0.999999999999396	0.949656750571509	338/2053/2690/3949/4023/255738/5360/7391	8
WP5173	Disorders of galactose metabolism 	8/3955	12/5488	0.776387155778963	0.999999999999396	0.949656750571509	231/2582/2592/2992/8908/5236/5836/6514	8
WP697	Estrogen metabolism	8/3955	12/5488	0.776387155778963	0.999999999999396	0.949656750571509	414/1312/1545/1576/2938/1728/412/54658	8
WP1545	miRNAs involved in DNA damage response	10/3955	15/5488	0.780094679965761	0.999999999999396	0.949656750571509	472/595/898/993/1021/1026/1385/406937/4609/5893	10
WP1742	TP53 network	10/3955	15/5488	0.780094679965761	0.999999999999396	0.949656750571509	472/27113/596/637/666/1026/1647/4193/4609/5366	10
WP1946	Cori cycle	10/3955	15/5488	0.780094679965761	0.999999999999396	0.949656750571509	2539/2597/2821/2875/3098/5214/5223/5230/6514/6888	10
WP22	IL-9 signaling pathway	10/3955	15/5488	0.780094679965761	0.999999999999396	0.949656750571509	3561/5604/5605/5595/5295/5296/6772/6774/6776/6777	10
WP3664	Regulation of Wnt / B-catenin signaling by small molecule compounds	10/3955	15/5488	0.780094679965761	0.999999999999396	0.949656750571509	324/8312/1499/27122/1856/8324/8325/4035/154141/8658	10
WP4558	Overview of interferons-mediated signaling pathway	10/3955	15/5488	0.780094679965761	0.999999999999396	0.949656750571509	3454/3455/3459/163702/10379/3717/5290/5295/6772/6773	10
WP497	Urea cycle and metabolism of amino groups	10/3955	15/5488	0.780094679965761	0.999999999999396	0.949656750571509	5832/435/1152/2628/162417/4942/4953/5831/6611/6723	10
WP5114	Nucleotide excision repair in xeroderma pigmentosum 	39/3955	57/5488	0.78044222434033	0.999999999999396	0.949656750571509	902/1022/1069/8450/1643/2068/2072/2074/1161/2965/2966/2967/404672/3150/3978/3980/4331/142/5424/5425/10714/5426/5427/54107/56655/5429/51426/56852/5887/9978/5981/5982/6117/84464/128710/7874/57654/56949/7508	39
WP313	Hepatocyte growth factor receptor signaling	23/3955	34/5488	0.782022934315728	0.999999999999396	0.949656750571509	1399/1793/2002/2353/2549/3082/3672/3688/5604/5605/11184/5595/5599/5058/5290/5728/2185/5781/5894/5908/6654/6714/6774	23
WP4288	MTHFR deficiency	12/3955	18/5488	0.785124546922753	0.999999999999396	0.949656750571509	836/842/55349/1119/56994/1312/79813/10919/4524/55471/10400/259230	12
WP4301	Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells	12/3955	18/5488	0.785124546922753	0.999999999999396	0.949656750571509	369/673/5595/22808/4893/10015/5873/5868/5878/5894/6237/22800	12
WP4532	Intraflagellar transport proteins binding to dynein	14/3955	21/5488	0.790771678127296	0.999999999999396	0.949656750571509	1778/1781/51143/79659/6993/6990/55764/9742/11020/112752/56912/28981/57728/57539	14
WP712	Estrogen signaling pathway	14/3955	21/5488	0.790771678127296	0.999999999999396	0.949656750571509	207/596/673/1147/1385/2002/2353/2782/8517/5604/5601/4790/5290/5566	14
WP2197	Endothelin pathways	16/3955	24/5488	0.796680382349169	0.999999999999396	0.949656750571509	153/488/10203/1264/1906/1909/1910/2769/2770/5604/4638/4846/4886/23236/5894/10267	16
WP5098	T-cell activation SARS-CoV-2	52/3955	76/5488	0.801601068607011	0.999999999999396	0.949656750571509	207/598/84433/6363/56477/595/920/941/942/1026/1147/1493/64798/2353/2534/9402/3122/3123/29851/3454/3455/8517/3594/3595/8809/64207/3708/3717/3932/3937/4049/10892/5604/5605/5595/4772/4790/4792/5170/5295/5335/5728/5894/5970/6009/253260/57521/6654/6775/7124/7248/7249	52
WP2636	Common pathways underlying drug addiction	18/3955	27/5488	0.802658652259189	0.999999999999396	0.949656750571509	60/72/107/369/814/1385/2705/2770/2893/5604/5605/5595/5499/5501/5566/5567/5894/5908	18
WP3998	Prader-Willi and Angelman syndrome	18/3955	27/5488	0.802658652259189	0.999999999999396	0.949656750571509	57194/595/894/990/1019/1021/1030/9638/8924/4193/4194/4692/123606/5108/5122/5590/5925/7337	18
WP3863	T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection	38/3955	56/5488	0.805441404090758	0.999999999999396	0.949656750571509	10598/207/84433/920/959/1019/11261/1147/1493/1739/2353/2534/9402/29851/8517/3932/3937/10892/5604/5605/5609/9020/1326/5595/5601/4690/4773/4790/4792/5058/5133/5163/5290/5335/5894/6237/6654/7124	38
WP4844	Influence of laminopathies on Wnt signaling	20/3955	30/5488	0.808598420161478	0.999999999999396	0.949656750571509	27161/324/8312/595/1021/1051/1052/1499/2010/2339/4000/5468/860/6696/6895/6932/83439/6934/7088/26092	20
WP4922	Mitochondrial complex IV assembly	20/3955	30/5488	0.808598420161478	0.999999999999396	0.949656750571509	152100/28958/388753/1352/1353/84987/285521/90639/116228/1327/9377/1337/1347/1349/1351/25994/4697/25953/389203/51204	20
WP400	p38 MAPK signaling pathway	22/3955	33/5488	0.81443759510317	0.999999999999396	0.949656750571509	1386/998/1385/1616/2002/3150/3315/5608/4214/4217/4293/9261/8550/4209/8569/4609/5321/5879/6464/6772/7046/8717	22
WP4880	Host-pathogen interaction of human coronaviruses - interferon induction	22/3955	33/5488	0.81443759510317	0.999999999999396	0.949656750571509	1147/5610/2353/64135/3454/3455/9641/8517/10379/5599/57506/4790/4792/4938/4939/4940/6772/6773/29110/148022/7187/7189	22
WP3584	MECP2 and associated Rett syndrome	33/3955	49/5488	0.817063228676799	0.999999999999396	0.949656750571509	207/50937/1052/1267/1385/1465/10664/1660/2247/2521/2530/2893/3185/3479/3481/4155/4204/4208/9611/4763/9315/84950/11168/5728/5978/6194/6446/25942/9126/6872/6890/200424/7337	33
WP4341	Non-genomic actions of 1,25 dihydroxyvitamin D3	42/3955	62/5488	0.818457743868293	0.999999999999396	0.949656750571509	818/857/6347/958/959/1594/1673/83982/10964/3569/9636/5600/6300/5603/5595/5599/5601/4790/4791/64127/4893/4939/23236/5330/5331/5332/5333/51196/5336/5580/5581/5590/6256/6257/6772/6773/7097/7099/51311/7124/7132/7421	42
WP3969	H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity	9/3955	14/5488	0.829975074487002	0.999999999999396	0.949656750571509	595/999/1019/1499/283120/5366/5925/6659/7289	9
WP4225	Pyrimidine metabolism and related diseases	9/3955	14/5488	0.829975074487002	0.999999999999396	0.949656750571509	1723/1806/51251/6240/6241/50484/7084/1890/7298	9
WP4337	ncRNAs involved in STAT3 signaling in hepatocellular carcinoma	9/3955	14/5488	0.829975074487002	0.999999999999396	0.949656750571509	3589/3569/3572/3717/4790/5970/6659/6774/6935	9
WP2289	Drug induction of bile acid pathway	7/3955	11/5488	0.833058625780584	0.999999999999396	0.949656750571509	5243/1244/10257/1576/8856/123264/7421	7
WP2290	RalA downstream regulated genes	7/3955	11/5488	0.833058625780584	0.999999999999396	0.949656750571509	998/55770/4893/5879/5898/10928/8531	7
WP3871	Valproic acid pathway	7/3955	11/5488	0.833058625780584	0.999999999999396	0.949656750571509	18/116285/1555/3030/3032/3028/3712	7
WP4553	FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma	7/3955	11/5488	0.833058625780584	0.999999999999396	0.949656750571509	54880/1848/8726/5595/84759/6045/23512	7
WP4629	Aerobic glycolysis	7/3955	11/5488	0.833058625780584	0.999999999999396	0.949656750571509	2023/2597/2821/3098/5213/5230/5315	7
WP4788	Autosomal recessive osteopetrosis pathways	7/3955	11/5488	0.833058625780584	0.999999999999396	0.949656750571509	4790/28962/29887/10312/8792/8600/7189	7
WP4919	Neuroinflammation	7/3955	11/5488	0.833058625780584	0.999999999999396	0.949656750571509	1147/2353/5599/4792/4843/5970/7099	7
WP286	IL-3 signaling pathway	30/3955	45/5488	0.836278182669763	0.999999999999396	0.949656750571509	207/572/596/598/942/1399/1439/5169/2353/2534/3055/3563/3717/4067/5604/5595/5599/5295/5296/5566/5781/5894/6464/6654/6714/6774/6776/6777/6850/7040	30
WP3851	TLR4 signaling and tolerance	17/3955	26/5488	0.837142064516927	0.999999999999396	0.949656750571509	1147/9641/8517/3569/3654/11213/3665/4790/4792/29110/148022/114609/7099/7124/7187/7189/23471	17
WP45	G1 to S cell cycle control	41/3955	61/5488	0.83987497598299	0.999999999999396	0.949656750571509	472/891/595/894/898/9134/901/902/993/1017/1019/1021/1022/1026/1028/1030/1385/10488/90993/84699/148327/1870/1871/1647/4174/4193/4331/4609/4999/5000/5001/23649/5426/5427/5557/5558/5925/6117/7027/7029/7465	41
WP481	Insulin signaling	103/3955	150/5488	0.849121185027798	0.999999999999396	0.949656750571509	207/375/382/10487/868/23624/9265/1958/30846/1977/1978/2002/5167/10211/2353/2308/2549/2887/2931/2992/3643/3667/8660/3799/3991/5604/5605/5606/5607/5608/5609/4214/4296/7786/9175/9020/10746/4215/4216/4217/9064/1326/4293/11184/5871/9448/5602/5600/6300/5603/5595/5597/5599/5601/50488/4641/5170/5211/5213/5286/5290/5291/5294/5295/5296/8503/5580/5590/5728/5770/5781/5792/5867/5879/5894/5967/6009/57381/23433/6195/6196/8986/27330/6198/6446/10110/6464/25759/8651/9021/6654/6655/6722/6810/6812/6813/252983/9882/57761/7248/7249/6844/7494	103
WP5205	Clock-controlled autophagy in bone metabolism	45/3955	67/5488	0.84992282216366	0.999999999999396	0.949656750571509	207/406/83734/55054/64422/10533/596/8553/79365/650/651/654/659/8646/9575/1435/115908/1513/128338/79443/3479/3569/3717/4041/84557/81631/4772/4862/9975/5187/9821/860/5176/4086/4089/4090/7040/8792/4982/8600/7189/10131/8408/7415/7474	45
WP5180	DYRK1A	36/3955	54/5488	0.850894401227895	0.999999999999396	0.949656750571509	84335/351/23621/836/842/595/1019/1021/1385/1408/10238/64798/28514/1759/1859/2247/2308/3092/26524/91750/132660/4772/5663/55851/5928/5934/5978/57521/23411/6598/10253/7023/7027/7029/7248/7249	36
WP4537	Hippo-Yap signaling pathway	14/3955	22/5488	0.867715855299705	0.999999999999396	0.949656750571509	3627/26524/11184/5871/9448/50488/4485/10397/11186/60485/6788/7003/8463/7004	14
WP384	Apoptosis modulation by HSP70	12/3955	19/5488	0.868066646779953	0.999999999999396	0.949656750571509	637/835/836/839/841/842/355/356/4214/5602/4790/7132	12
WP4863	Host-pathogen interaction of human coronaviruses - autophagy	12/3955	19/5488	0.868066646779953	0.999999999999396	0.949656750571509	83734/55054/89849/64422/115201/10533/84557/9821/8408/9706/55062/53349	12
WP4656	Joubert syndrome	44/3955	66/5488	0.868164630608538	0.999999999999396	0.949656750571509	54806/203286/200894/403/80210/468/472/27077/583/55212/57545/9738/9731/22897/80184/95681/1069/1855/2316/27130/54903/4644/284086/261734/8481/142/5108/5116/5145/117177/4218/10111/6009/387/6102/23322/6469/79600/79867/79583/65062/91147/123016/23090	44
WP3529	Zinc homeostasis	18/3955	28/5488	0.869798064303069	0.999999999999396	0.949656750571509	4493/4494/4495/4496/4499/7779/55532/7782/64924/148867/27173/91252/23516/29985/283375/25800/7922/64116	18
WP5027	nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell	10/3955	16/5488	0.87000333919325	0.999999999999396	0.949656750571509	1965/8894/8661/8662/3646/8665/8667/8668/8669/1983	10
WP732	Serotonin receptor 2 and ELK-SRF/GATA4 signaling	10/3955	16/5488	0.87000333919325	0.999999999999396	0.949656750571509	2002/2776/3708/5604/5605/5595/9261/4893/5894/6722	10
WP2435	Quercetin and Nf-kB / AP-1 induced apoptosis	8/3955	13/5488	0.874446599270445	0.999999999999396	0.949656750571509	8309/2353/7975/4312/4790/4792/5743/7422	8
WP3853	ERK pathway in Huntington's disease	8/3955	13/5488	0.874446599270445	0.999999999999396	0.949656750571509	836/1385/1956/2002/3064/5609/4915/5894	8
WP4705	Pathways of nucleic acid metabolism and innate immune sensing	8/3955	13/5488	0.874446599270445	0.999999999999396	0.949656750571509	103/64135/57506/4938/10535/6041/25939/11277	8
WP4962	Airway smooth muscle cell contraction	8/3955	13/5488	0.874446599270445	0.999999999999396	0.949656750571509	154/952/2776/3710/4638/23236/387/9475	8
WP4753	Nucleotide excision repair	28/3955	43/5488	0.881513545892594	0.999999999999396	0.949656750571509	902/1022/1069/8450/1643/2068/2072/2074/1161/2965/2966/2967/404672/3978/4331/5424/5425/10714/5426/5427/54107/56655/5887/9978/5981/5982/6117/7508	28
WP5050	TCA cycle in senescence	6/3955	10/5488	0.883076524175854	0.999999999999396	0.949656750571509	673/2805/4199/4200/5163/57546	6
WP3865	Novel intracellular components of RIG-I-like receptor (RLR) pathway	34/3955	52/5488	0.889719651694457	0.999999999999396	0.949656750571509	64343/843/841/1147/3627/6387/1540/1654/79132/64135/9641/8517/3665/9636/4214/5602/5600/6300/5603/5599/5601/57506/4790/4792/5970/54941/80143/10010/29110/9755/7124/8717/7187/7189	34
WP585	Interferon type I signaling pathways	34/3955	52/5488	0.889719651694457	0.999999999999396	0.949656750571509	1385/1399/1975/1977/1978/2534/3454/3455/10379/3667/8660/3932/5606/5608/4214/27250/10401/5295/5296/3276/5781/5879/5966/6194/8986/6198/57521/8651/9021/6772/6773/6774/6775/6776	34
WP2884	NRF2 pathway	74/3955	110/5488	0.891094006343632	0.999999999999396	0.949656750571509	1244/10257/218/645/873/874/1066/8824/1958/1969/2042/2258/2539/2729/2678/2877/2878/2936/2938/2939/2947/2950/1839/3082/3162/3320/23764/4199/4259/1728/3084/5155/5226/5467/5052/9588/6256/5265/81031/66035/154091/6514/6515/6518/11182/29988/27173/91252/23516/29985/283375/25800/7922/64116/115584/159963/6527/8884/160728/200010/11254/340024/6532/6533/6534/6535/23657/6649/7039/7040/7048/7295/114112/54658	74
WP3298	Melatonin metabolism and effects	19/3955	30/5488	0.896055627926945	0.999999999999396	0.949656750571509	43/153/348/406/9575/1408/1453/1454/1545/1906/2308/3654/4128/406938/4790/5187/8864/23411/7189	19
WP241	One-carbon metabolism	15/3955	24/5488	0.89615040092051	0.999999999999396	0.949656750571509	23382/10840/275/55349/1719/2346/2618/123263/4522/25902/10797/4524/6472/6948/7298	15
WP2875	Constitutive androstane receptor pathway	15/3955	24/5488	0.89615040092051	0.999999999999396	0.949656750571509	5243/1244/211/1555/1576/1577/2308/2939/3320/8648/10499/23054/10891/6256/54658	15
WP78	TCA cycle (aka Krebs or citric acid cycle)	11/3955	18/5488	0.900158341602997	0.999999999999396	0.949656750571509	50/1743/3418/3419/3421/4967/6391/6392/8803/8802/8801	11
WP2038	Microtubule cytoskeleton regulation	27/3955	42/5488	0.901008546902016	0.999999999999396	0.949656750571509	207/324/814/998/1073/6249/1808/1855/2048/2151/2776/3984/4131/9261/22919/2011/5058/90102/5290/5566/5728/5879/6714/6774/3925/10420/11076	27
WP4396	Nonalcoholic fatty liver disease	91/3955	135/5488	0.904898334543479	0.999999999999396	0.949656750571509	79602/207/10000/468/578/27113/10018/637/836/841/6347/998/1327/9377/1337/1346/1347/9167/1349/1351/9451/1965/2081/355/356/2931/3552/3553/3569/3643/3667/8660/83737/3953/4296/4217/5599/5601/6945/22877/51085/4694/4695/4696/4697/56901/4698/4701/4704/4706/4707/4716/4709/4710/4714/4717/4718/4719/4724/4725/374291/4723/4790/5290/5291/5295/5296/8503/5313/5465/5564/5565/5571/51422/5879/5970/6256/6391/6392/4092/9021/7040/7124/7132/7381/7384/7386/7388/7412/81671/7494	91
WP47	Hedgehog signaling pathway	7/3955	12/5488	0.912398683782853	0.999999999999396	0.949656750571509	406/2736/2737/3549/6469/25942/6608	7
WP5171	Leukotriene metabolic pathway	7/3955	12/5488	0.912398683782853	0.999999999999396	0.949656750571509	4363/241/4051/26063/1800/2678/2687	7
WP4932	7q11.23 copy number variation syndrome	54/3955	82/5488	0.915219921163042	0.999999999999396	0.949656750571509	83451/31/32/468/64756/91647/23476/695/1028/9076/1365/1364/7122/7461/1499/9188/1743/84277/9451/2074/355/2199/10516/2200/2597/23426/2969/9569/3066/10013/3984/5595/51085/10514/4609/4641/3084/23636/4967/5313/5592/5925/5982/6804/26608/7324/9246/29914/8408/7391/6844/51160/79720/9605	54
WP2873	Aryl hydrocarbon receptor pathway	20/3955	32/5488	0.917109689035567	0.999999999999396	0.949656750571509	196/9049/218/11140/1545/1956/2033/2939/3320/3553/3726/26509/8648/1728/51426/8140/6714/7040/7124/54658	20
WP524	G13 signaling pathway	22/3955	35/5488	0.917208829854996	0.999999999999396	0.949656750571509	998/1073/11113/10672/8826/10788/3984/4216/5602/5216/5290/5291/5296/5879/387/85415/9475/6198/6242/57630/7454/8976	22
WP534	Glycolysis and gluconeogenesis	24/3955	38/5488	0.917659105789854	0.999999999999396	0.949656750571509	230/1737/2023/2203/2597/2805/2821/3098/3099/3101/51660/25874/5091/5105/5211/5213/5214/5223/5230/5313/5315/6514/6515/6518	24
WP366	TGF-beta signaling pathway	85/3955	127/5488	0.918291865108984	0.999999999999396	0.949656750571509	207/351/1386/467/8312/9564/8945/857/595/998/1026/1030/1278/10987/1387/8454/1601/163126/2033/2335/2353/2354/50943/83737/3673/3688/3690/3691/3726/3985/5604/5605/5606/5608/11184/5599/5601/4208/4312/4321/4609/23327/4739/9972/5062/5163/5295/5296/64219/5371/5494/5879/5894/5934/9978/387/54778/860/6464/25942/6497/4088/4089/4092/64750/6654/6714/11171/7027/7040/7041/7046/7048/7049/7050/7057/3371/7189/10131/51377/10413/6935/9839/9765/9372	85
WP2036	TNF-related weak inducer of apoptosis (TWEAK) signaling pathway	26/3955	41/5488	0.918379887837111	0.999999999999396	0.949656750571509	207/329/330/836/841/6347/1147/1499/3569/9020/5595/5599/5601/4318/4790/4791/4792/5879/5894/5970/7124/51330/8742/7185/7187/7188	26
WP4861	Endoplasmic reticulum stress response in coronavirus infection	26/3955	41/5488	0.918379887837111	0.999999999999396	0.949656750571509	468/22926/596/5610/9451/1965/2081/3309/84557/5599/51360/5499/5501/6992/4660/54776/23368/26472/23645/84919/84988/5504/5507/90673/55607/7494	26
WP2112	IL-17 signaling pathway	16/3955	26/5488	0.918429771086615	0.999999999999396	0.949656750571509	207/1051/1052/8517/23765/55540/132014/3717/9020/5595/4790/5290/5970/6774/7187/7189	16
WP1528	Physiological and pathological hypertrophy of the heart	14/3955	23/5488	0.920191302389478	0.999999999999396	0.949656750571509	1906/2353/3572/5606/5600/5599/50804/4776/5530/5532/5581/5879/387/6774	14
WP2507	Nanomaterial induced apoptosis	12/3955	20/5488	0.923031522517282	0.999999999999396	0.949656750571509	578/596/637/836/839/841/842/8837/56616/355/356/5551	12
WP4949	16p11.2 proximal deletion syndrome	40/3955	62/5488	0.927200630771351	0.999999999999396	0.949656750571509	2186/841/10576/22948/908/10574/10694/10423/11151/7430/79153/8479/3476/283899/253980/58508/8085/5606/5608/5595/4478/9961/4790/2908/79447/143/22976/5468/5528/9989/5728/23475/5966/26470/9344/7189/23025/10497/83719/653808	40
WP100	Glutathione metabolism	10/3955	17/5488	0.927351093011285	0.999999999999396	0.949656750571509	2539/2729/2678/2687/2876/2877/2878/2879/2936/2938	10
WP1584	Type II diabetes mellitus	10/3955	17/5488	0.927351093011285	0.999999999999396	0.949656750571509	773/3643/3667/5599/5256/23533/5580/5590/6514/7124	10
WP4921	Mitochondrial complex III assembly	8/3955	14/5488	0.93374196564837	0.999999999999396	0.949656750571509	90624/54902/55245/84300/7381/7384/7386/7388	8
WP5200	Dravet syndrome	8/3955	14/5488	0.93374196564837	0.999999999999396	0.949656750571509	207/5600/4790/5290/55615/79899/253260/6328	8
WP107	Translation factors	29/3955	46/5488	0.934366892929005	0.999999999999396	0.949656750571509	1915/1933/1938/29904/5610/9451/8892/8891/1965/8894/8661/8662/3646/8665/8667/8668/8669/1974/1975/1977/1978/1979/1981/8672/1983/1984/9669/2107/10605	29
WP4324	Mitochondrial complex I assembly model OXPHOS system	29/3955	46/5488	0.934366892929005	0.999999999999396	0.949656750571509	28976/51295/55572/4694/4695/4696/4698/4701/4706/51103/91942/25915/29078/137682/55471/4707/4716/4709/4710/4714/4717/4718/4719/4724/4725/4723/80224/55863/54968	29
WP2361	Gastric cancer network 1	13/3955	22/5488	0.940478613745342	0.999999999999396	0.949656750571509	86/324/6790/55125/144455/1894/54891/56992/9585/4605/57122/8607/64094	13
WP4206	Hereditary leiomyomatosis and renal cell carcinoma pathway	11/3955	19/5488	0.944284421984683	0.999999999999396	0.949656750571509	31/32/8452/54583/3091/5163/5564/5571/6194/4891/7422	11
WP623	Oxidative phosphorylation	22/3955	36/5488	0.947413956434448	0.999999999999396	0.949656750571509	537/10159/3002/4695/4696/4697/56901/4698/4701/4704/4706/4707/4716/4710/4714/4717/4718/4719/4724/4725/374291/4723	22
WP2453	TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc)	9/3955	16/5488	0.949528658223227	0.999999999999396	0.949656750571509	47/48/1737/1743/3419/4967/5091/5105/8801	9
WP4884	Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex	9/3955	16/5488	0.949528658223227	0.999999999999396	0.949656750571509	920/926/2534/3122/3123/3569/3932/64386/55922	9
WP5037	Riboflavin and CoQ disorders	7/3955	13/5488	0.956676115713995	0.999999999999396	0.949656750571509	54840/27235/57017/2110/23590/55065/79581	7
WP5111	Familial hyperlipidemia type 4	7/3955	13/5488	0.956676115713995	0.999999999999396	0.949656750571509	84532/355/3949/4023/4035/5360/6400	7
WP4906	3q29 copy number variation syndrome	31/3955	50/5488	0.956810775624375	0.999999999999396	0.949656750571509	102/207/84984/9857/1739/79659/6993/6990/200933/55294/3077/3091/9587/4609/375387/5062/93183/80235/8503/165918/255812/205564/23411/30061/123264/6776/6777/7037/7040/7334/26043	31
WP4655	Cytosolic DNA-sensing pathway	35/3955	56/5488	0.957082240202316	0.999999999999396	0.949656750571509	103/9447/834/843/841/6351/1147/3627/1540/9641/8517/3606/3553/90865/3569/3665/9636/57506/4790/4792/9533/5440/55703/10623/661/10621/10622/171568/5970/11035/54941/29110/8717/11277/81030	35
WP3925	Amino acid metabolism	47/3955	74/5488	0.959786707688122	0.999999999999396	0.949656750571509	30/34/47/50/84532/128/5832/8639/440/549/586/875/1491/1644/1743/2184/10056/2744/2752/2805/84706/2936/3067/26275/3158/23395/4128/92935/56922/4357/4942/4953/4967/5091/5105/8050/5166/5315/151742/5831/10993/6611/6723/8802/6898/6999/7166	47
WP5117	Cohesin complex - Cornelia de Lange syndrome	17/3955	29/5488	0.96199380716817	0.999999999999396	0.949656750571509	324/114799/9700/55869/23383/25836/23244/5347/5519/5525/5526/5528/5529/9985/9126/10735/10734	17
WP2525	Trans-sulfuration and one-carbon metabolism	15/3955	26/5488	0.964133943529858	0.999999999999396	0.949656750571509	10768/23382/275/875/1491/1719/2729/4522/25902/10797/441024/4524/29968/6472/7298	15
WP2333	Trans-sulfuration pathway	5/3955	10/5488	0.966316437312854	0.999999999999396	0.949656750571509	875/51380/1491/2805/4357	5
WP3930	EDA signaling in hair follicle development	5/3955	10/5488	0.966316437312854	0.999999999999396	0.949656750571509	649/10913/6469/25928/7473	5
WP5108	Familial  hyperlipidemia type 1	5/3955	10/5488	0.966316437312854	0.999999999999396	0.949656750571509	3949/4023/4035/5360/6400	5
WP268	Notch signaling	24/3955	40/5488	0.966711042230918	0.999999999999396	0.949656750571509	6868/83464/1387/1488/28514/54567/1840/151636/23220/1855/1856/3066/51763/3714/8850/9794/55534/4853/4854/4855/9253/5663/5664/3516	24
WP5220	Metabolic reprogramming in pancreatic cancer	24/3955	40/5488	0.966711042230918	0.999999999999396	0.949656750571509	47/587/1737/2194/64841/2805/2821/2875/3098/3099/3156/3158/3949/4199/8050/5211/5238/5315/22934/6510/8501/8140/6646/6675	24
WP5182	Pro-survival signaling of neuroprotectin D1	8/3955	15/5488	0.966823450653518	0.999999999999396	0.949656750571509	330/836/841/842/11035/7124/7132/8717	8
WP5085	Vasopressin-regulated water reabsorption	22/3955	37/5488	0.967611280252873	0.999999999999396	0.949656750571509	112/115/360/1385/10488/90993/84699/148327/9586/10671/1778/1781/51143/79659/4905/5566/5567/8766/5868/5878/6810/6844	22
WP4946	DNA repair pathways, full network	71/3955	110/5488	0.96789899418109	0.999999999999396	0.949656750571509	472/545/675/902/1022/1069/1111/8450/64421/1643/2068/2072/2074/1161/9156/22909/2176/2189/55120/2237/2965/2966/2967/404672/3978/3980/8930/4292/4331/4350/4436/4437/2956/4595/4683/252969/55247/4968/142/10038/5395/11284/5423/5424/5425/10714/5426/5427/54107/56655/5429/51426/27343/27434/5887/10111/5893/9978/51455/5981/5982/6117/23583/6996/7014/7398/57599/7486/7508/7518/7520	71
WP500	Glycogen synthesis and degradation	20/3955	34/5488	0.968773984132096	0.999999999999396	0.949656750571509	2931/2992/8908/3098/3099/3101/80201/5236/5255/5256/5519/5523/28227/5525/5526/5528/5529/5834/5836/7360	20
WP2583	T cell receptor and co-stimulatory signaling	16/3955	28/5488	0.972072402073957	0.999999999999396	0.949656750571509	207/926/1493/1859/8445/2534/2931/3932/4773/4790/4792/5133/5163/5335/5530/5728	16
WP4923	Autophagy	16/3955	28/5488	0.972072402073957	0.999999999999396	0.949656750571509	84335/55054/64422/10533/79065/64798/81631/5564/5565/5571/51422/9821/57521/8408/7405/26100	16
WP4022	Pyrimidine metabolism	47/3955	75/5488	0.972190215775117	0.999999999999396	0.949656750571509	978/56474/1633/1635/1723/1806/1841/5167/5169/953/956/4830/4833/29922/87178/5422/23649/5424/5425/10714/5426/5427/54107/56655/25885/9533/5436/5440/55703/10623/661/10621/10622/171568/5557/5558/6240/6241/50484/7083/7084/1890/7298/83549/7371/54963/7378	47
WP5072	Modulators of TCR signaling and T cell activation	36/3955	59/5488	0.976994678655252	0.999999999999396	0.949656750571509	26523/207/84433/868/1147/8065/1606/8525/9158/10672/9402/8517/3932/3937/10892/9020/1326/11184/4209/4716/4790/4792/5094/5170/5295/5296/5335/5966/5970/58490/10019/6598/8651/7128/7189/677	36
WP4320	Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome	12/3955	22/5488	0.97703899341374	0.999999999999396	0.949656750571509	11335/23468/1107/1108/3066/51763/53615/9112/57504/5925/5928/6839	12
WP4159	GABA receptor signaling	7/3955	14/5488	0.979610265779621	0.999999999999396	0.949656750571509	18/223/1175/2550/2555/2564/2568	7
WP2359	Parkin-ubiquitin proteasomal system pathway	35/3955	58/5488	0.981606958324214	0.999999999999396	0.949656750571509	834/841/898/8454/55294/3304/3305/3309/3310/5701/5704/5707/5716/5717/5718/5719/10213/9861/5713/25897/6478/9627/10273/7846/10376/7277/79861/7280/347733/10383/84617/7326/51465/7332/9246	35
WP4577	Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway	25/3955	43/5488	0.983936675448301	0.999999999999396	0.949656750571509	31/84335/83734/55054/23130/64422/115201/10533/1356/80067/64798/79152/84557/4204/8398/9821/6009/57521/6342/7248/7249/8408/11152/55062/26100	25
WP5222	2q13 copy number variation syndrome	25/3955	43/5488	0.983936675448301	0.999999999999396	0.949656750571509	382/80117/10018/1435/2625/3552/3553/3554/3556/3557/3569/3958/10461/5336/25885/9533/5440/23550/5879/727851/8651/9021/6772/150465/376940	25
WP2916	Interactome of polycomb repressive complex 2 (PRC2) 	8/3955	16/5488	0.984118243083808	0.999999999999396	0.949656750571509	8726/8178/2145/22823/5928/11329/23512/23087	8
WP3959	DNA IR-double strand breaks and cellular response via ATM	30/3955	51/5488	0.986218117637219	0.999999999999396	0.949656750571509	86/1386/472/545/578/637/675/836/842/1020/1111/11200/64421/9156/3297/9656/4193/4683/142/5884/10111/5893/5883/11186/9126/6788/7014/7189/5976/10413	30
WP2446	Retinoblastoma gene in cancer	53/3955	86/5488	0.987351178625836	0.999999999999396	0.949656750571509	54443/580/890/891/595/898/9134/993/994/8317/1017/1019/1021/1026/1111/1633/1719/1870/1871/2189/3148/24137/5603/4193/2956/4609/4863/5422/10714/5426/5427/5557/5877/5894/5925/5928/5947/6117/6240/6241/8819/25942/6595/10592/9126/3925/6839/7027/7029/7272/7298/7465/79027	53
WP4352	Ciliary landscape	126/3955	194/5488	0.988955455584092	0.999999999999396	0.949656750571509	2181/10939/10555/9255/203286/324/57136/26286/92482/583/55212/875/64072/1039/9859/80184/23059/23019/246175/8533/51138/10987/10980/50813/1387/1488/1499/5476/80344/10238/1655/80005/1778/1781/51143/6993/6990/1892/9343/30845/9669/55763/55770/60412/54536/23233/23404/54512/23016/5393/79018/54994/2717/2720/3066/55764/9742/26160/11020/112752/56912/51098/55081/28981/27152/9657/8826/10788/128239/167691/3934/10128/54585/10982/55388/4174/84515/54903/4436/4637/140465/4698/4704/284086/4790/22981/10726/4927/5048/10424/9883/5704/5718/5719/5713/5866/4218/79874/5879/5899/57610/5925/10432/64795/64777/6103/6629/55812/8636/2040/9882/11018/85456/79989/150737/123016/7328/55245/10083/7431/27183/7465/63929/10413/116225/79699	126
WP4224	Purine metabolism and related disorders	10/3955	20/5488	0.990329677180595	0.999999999999396	0.949656750571509	158/270/316/2618/3614/3704/10606/4860/5471/50484	10
WP111	Electron transport chain: OXPHOS system in mitochondria	41/3955	69/5488	0.992107780907854	0.999999999999396	0.949656750571509	1353/1327/9377/1337/1346/1347/9167/1349/1351/4694/4695/4696/4697/4698/4701/4704/4706/4707/4716/4709/4710/4714/4717/4718/4719/4724/4725/374291/4723/6341/6391/6392/9016/9481/291/292/293/7381/7384/7386/7388	41
WP5046	NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence	11/3955	22/5488	0.992440466279766	0.999999999999396	0.949656750571509	2539/2805/3553/3569/10135/142/5925/5970/23411/23410/23408	11
WP4792	Purine metabolism	5/3955	12/5488	0.994142142113354	0.999999999999396	0.949656750571509	158/270/3614/3704/4860	5
WP691	Tamoxifen metabolism	6/3955	14/5488	0.995119419426178	0.999999999999396	0.949656750571509	1545/1558/1576/1577/2326/54575	6
WP4595	Urea cycle and associated pathways	10/3955	21/5488	0.995411447484087	0.999999999999396	0.949656750571509	8659/435/2805/2875/162417/4843/4846/4942/5831/10166	10
WP2363	Gastric cancer network 2	14/3955	28/5488	0.996365806721974	0.999999999999396	0.949656750571509	55299/27101/1499/79075/1956/157769/84823/92140/4609/51316/5884/255488/6277/29089	14
WP405	Eukaryotic transcription initiation	22/3955	41/5488	0.996445093531687	0.999999999999396	0.949656750571509	902/1022/2068/2959/2963/2965/2966/2967/3611/4331/25885/5436/5440/55703/661/171568/6884/6877/6878/6879/6880/6908	22
WP3878	ATM signaling in development and disease 	22/3955	42/5488	0.998072416273437	0.999999999999396	0.949656750571509	1386/472/23300/545/1020/8851/1111/11200/64421/2539/9759/3150/3315/8517/4217/9656/4683/4790/10111/5932/165918/7249	22
WP466	DNA replication	21/3955	41/5488	0.998698277815955	0.999999999999396	0.949656750571509	990/8317/1017/55388/4174/4999/5000/5001/5422/23649/5424/5425/10714/5426/5427/5557/5558/5981/5982/6117/7316	21
WP179	Cell cycle	65/3955	113/5488	0.999724743281506	0.999999999999396	0.949656750571509	10393/25847/51433/51434/472/545/890/891/595/894/898/9134/902/8556/8555/991/8697/993/994/996/990/8317/1017/1019/1021/1022/1026/1028/1030/1111/11200/8454/1870/1871/2033/9700/1647/4616/10912/3066/10459/4174/4193/4609/4999/5000/5001/5347/5925/5934/9978/2810/4088/4089/9126/10735/7027/7029/7040/7043/7272/7465/7531/7532/7534	65
WP4016	DNA IR-damage and cellular response via ATR	40/3955	75/5488	0.999841261126113	0.999999999999396	0.949656750571509	472/545/84126/580/675/1017/22897/1111/11200/9521/9156/2237/2305/8924/3364/8517/9656/4193/4292/4436/4683/142/5347/5371/5423/5884/10111/5893/5883/5932/5965/9400/80010/6117/6601/51720/5976/7398/7486/7520	40
WP4240	Regulation of sister chromatid separation at the metaphase-anaphase transition	4/3955	15/5488	0.999958986824548	0.999999999999396	0.949656750571509	991/9700/4085/9126	4
WP411	mRNA processing	62/3955	122/5488	0.999999849552306	0.999999999999396	0.949656750571509	51362/10658/10659/1195/1198/57396/10978/29894/53981/51692/1478/23283/1479/11218/8449/1660/9343/2521/3181/3184/3188/10236/57819/51690/11051/10914/5094/84844/5496/3276/9129/9128/24148/10594/5681/5725/58155/9584/10181/8175/10262/83443/6626/6628/6629/6632/6635/6636/6637/140890/6729/6733/10772/6427/6428/6431/57794/10147/6829/10972/10907/22803	62
WP477	Cytoplasmic ribosomal proteins	30/3955	84/5488	0.999999999999396	0.999999999999396	0.949656750571509	9801/4736/6135/6139/6143/9349/6147/6154/6161/6164/6125/6128/6129/6132/6133/6175/6181/6208/6210/6222/6224/6228/6189/6194/6195/6196/27330/6198/6201/6202	30
